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Introduction and outline of the thesis 
 
Introduction 
Crohn' s disease and ulcerative colitis are chronic inflammatory diseases of the gastrointestinal 
tract. They are collectively named as Inflammatory Bowel Diseases (IBD). The prevalence of 
Crohn's disease and ulcerative colitis is both about 50/100.000 (together about 1/1000). They 
are identified and diagnosed by the appearance of a set of clinical, endoscopic, and histologic 
characteristics. In ulcerative colitis the inflammatory response is largely restricted to the 
mucosa and submucosa, but in Crohn's disease inflammation extends through the intestinal 
wall from mucosa to serosa. Ulcerative colitis is restricted to the colon and, and colectomy is 
curative. In contrast, Crohn's disease has the potential to involve the patient's entire 
gastrointestinal tract, but is mainly present in the colon and terminal ileum. Resection of the 
inflamed segment is not curative in Crohn's disease, and inflammation is likely to recur 
proximal of the anastomosis. The inflammation in ulcerative colitis is continuous from the anus 
to the proximal margin, whereas, in Crohn's disease normal mucosa may be present between 
affected areas (skipp leasions) 1. Smoking is known to cause exacerbations in Crohn's disease. 
In contrast, in ulcerative colitis smoking may attenuate manifestations of disease 1,2. Despite 
these differences, there is a group of patients whose clinical picture falls between the two 
diseases: these patients have indeterminate colitis. 
The etiology and pathogenesis of ulcerative colitis and Crohn's disease are not known. 
Presumably, both diseases have a multifactoral origin in which several genes, 
environmental factors, a dysregulated immune response, a disturbed barrier between 
intestinal lumen and mucosal immune system, and the commensal microflora may be 
important 1. 
 
Genes in the pathogenesis of IBD 
In siblings and offspring of IBD patients there is a 7% lifetime risk of developing IBD 3. 
Monozygotic twins are even 45% concordant for Crohn's disease 1. This suggests a genetic 
factor or genetic factors. Variants of the CARD15-gene have been identified to have a strong 
association with Crohn's disease. The product of the CARD15-gene is located within 
macrophages, has a binding site for bacterial lipopolysaccharide and perhaps plays a role in 
regulating nuclear factor-kappa B activation and macrophage apoptosis 4. Persons who are 
homozygous for variant CARD15 may have a 20-fold or more increase in susceptibility to 
Crohn's disease, with a particular predilection for ileal disease. Only 4% of patients with 
Crohn's disease are homozygous for these CARD15 variants opposed to 0.02% in controls and 
patients with ulcerative colitis 1.  
 
Environmental factors in the pathogenesis of IBD 
The incidence and prevalence of Crohn's disease and ulcerative colitis vary greatly in different 
geographic locations. The highest prevalence rates are in northern Europe and North America, 
whereas very low rates are found in Africa, Asia and South America 5. Although genetic factors 
may explain some of these differences, environmental factors may also be important. Smoking, 
as mentioned above, is a strong environmental factor affecting both ulcerative colitis and 
Crohn's disease albeit in opposing ways 2. Also the intestinal microflora can be considered as 
an environmental factor that most probably plays a role in the pathogenesis of Crohn’s disease. 





Mucosal immune response in the pathogenesis of IBD 
Clear evidence exist for activation of the mucosal immune response in IBD. The lamina 
propria is infiltrated with lymphocytes and macrophages and there is a 10 fold increase in the 
amount of plasma cells with a shift towards IgG and IgM producing plasma cells in the 
inflamed mucosa 6. Also the production of proinflammatory cytokines (IL-1, IL-6, TNF-alpha) 
is increased within the inflamed mucosa 7. The mucosa of patients with Crohn's disease is 
dominated by CD4+ lymphocytes with a type 1 helper-T-cell (Th1) phenotype, characterised 
by the production of interferon-gamma and interleukin-2. In contrast, the mucosa in patients 
with ulcerative colitis is dominated by CD4+ lymphocytes with a type 2 helper-T-cell 
phenotype (Th2), characterised by the production of TGF-beta and interleukin-5 1. Presumably 
Th1 cytokines activate macrophages, which in turn, produce interleukin-12 and interleukin-18, 
tumor necrosis factor (TNF), interleukin-1, and interleukin-6 1.  
An immune response is either initiated by a specific antigen (a normal immune response to an 
antigen), or by a loss of factors that normally suppress or preclude an immune response (an 
abnormal immune response to an ‘autoantigen’. 
 
Prevention of mucosal immune reactivity 
In healthy individuals, a low-grade chronic inflammation is present in the intestinal mucosa. 
Presumably, this chronic inflammation is a product of chronic exposure of the mucosa to 
lumenal antigens, as evidenced by the absence of IgA secreting plasma cells in the gut lamina 
propria of germfree and antigen free mice 8. Failure to suppress this immune response could 
result in an uncontrolled mucosal immune activation as seen in IBD. 
Apart from the epithelial-mucus barrier there are powerful mechanisms that prevent 
mucosal inflammation: (a) phagocytosis of bacteria that have penetrated into the 
mucosa and (b) mucosal immunological tolerance for the antigens of commensal 
bacteria that have penetrated into the mucosa.  
Findings by Duchmann et al. suggest that there exists some sort of mucosal tolerance 
for an individual's own microflora. Their data show that mucosal T cells, isolated from 
the colon of healthy individuals, do not proliferate in response to commensal colonic 
bacteria derived from the same individual whereas these T cells proliferate in the 
presence of bacteria derived from another individual. In marked contrast, however, 
mucosal T cells from IBD patients with active disease proliferate intensely when 
incubated with commensal bacteria derived from the same patient 9. This suggests that 
the normal mucosal tolerance may be disrupted in IBD patients. How tolerance at 
mucosal sites is regulated is not exactly known, but it is clear that many different cells, 
cytokines and other factors are involved. Current theories suggest a role for the so 
called mucosal regulatory Tr1 cells in maintaining tolerance. Tr1 cells are antigen-
specific mucosal CD4+ T cells that produce large amounts of Il-10 in response to 
antigen recognition. Il-10 may suppress activation of other T cells in the local 
environment hereby inducing a more general mucosal tolerance including the humoral 
immune response 10. 
 
The epithelial-mucus barrier in IBD 
In healthy individuals, a single layer of epithelial cells and mucus separates the abundant 
luminal antigens from an extensive mucosal immune system. It is not known whether the 
gelatinous thick mucus layer that contains large amounts of dimeric IgA precludes direct 
contact between commensal bacteria and epithelial cells. A temporary loss of mucosal barrier 
function (resulting in an influx of commensal bacteria and their antigens into the mucosa) due 
10
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to bacterial or viral enteric infections 11, NSAIDs 12 or hypersensitivity reactions to food 
antigens 13,14, may precipitate exacerbations of Crohn's disease in susceptible patients. On the 
other hand, anticancer therapy in non-IBD patients may lead to extensive mucosal sloughing, 
yet this heals within days without causing a chronic colitis. 
 
Intestinal microflora in the pathogenesis of IBD 
The human intestinal tract harbors a complex microbial ecosystem, usually referred to as the 
normal commensal microflora (see below). Circumstantial evidence suggests that the 
commensal intestinal bacterial flora may play a role in the pathogenesis of IBD 15,16. This 
conclusion is based on the following arguments: (i) IBD occurs most frequently in intestinal 
regions colonised by the highest bacterial concentrations (colon and terminal ileum); (ii) 
Crohn's disease (but not ulcerative colitis) may improve when lumenal bacterial concentrations 
are reduced by elemental diets 13,14, split ileostomy 17, 18, intestinal lavage 19 or broad spectrum 
antibiotics 20, 21; (iii) in Crohn's disease rechallenge of an excluded colon or neoterminal ileum 
with autologous intestinal contents results in mucosal inflammation 22; (iv) there are several 
animal models (for instance mice with a targeted deletion for T cell receptor alpha, IL-2 or IL-
10 and rats transgenic for HLA-B27) that develop colitis when they are maintained under 
conventional conditions but not under germfree conditions 23-26. Collectively, these data suggest 
that the presence of indigenous bacteria is required for the induction of intestinal inflammation 
in Crohn's disease and possibly also in ulcerative colitis.  
Presumably, the combination of (a) an inappropriate mucosal immune response, (b) a reduction 
of the epithelial-mucus barrier and (c) large amounts of bacterial antigens may be responsible 
for the initiation and perpetuation of the chronic inflammation. 
 
Normal commensal intestinal microflora 
The normal commensal microflora consists mainly (>99.9 %) of obligatory anaerobic bacteria. 
The highest bacterial concentrations are found in the colon and terminal ileum: 1010 - 1012 
bacteria per gram intestinal content. The normal microflora has many beneficial functions: 
synthesis of vitamin K and growth factors for host intestinal cells, prevention of outgrowth of 
potentially pathogenic bacteria (colonization resistance), stimulation of intestinal motility, 
promotion of the enterohepatic circulation by deconjugation of bile acids, stimulation and 
maturation induction of the gut immune system and modulation of the expression of a number 
of epithelial genes 27-29. Each individual has a characteristic commensal colon microflora that is 
relatively stable over time 30. Little is known about the composition of the microflora and 
possible differences in composition between the different colon regions, terminal ileum and 
faeces.  
In the last ten years a new method has been developed to study bacteria without culturing: 
Fluorescence In Situ Hybridisation (FISH). FISH has proven to be a very powerful technique 
for the study of fecal anaerobic bacteria. All bacteria have 10,000 -100,000 copies of ribosomal 
16S rRNA which contains conserved regions (i.e. conserved for all bacteria), variable regions 
(i.e. conserved for each group of bacteria) and hypervariable regions (i.e. typical for specific 
bacterial strains). In this way 16S rRNA-targeted oligonucleotide probes can be constructed 
with specificity for all bacteria (BACT338), certain groups of bacteria (for instance BIF164 
which specifically hybridises with Bifidobacteria) or specific bacterial strains. If a fluorescent 
lable is attached to these probes, hybridised bacteria can be visualised under a fluorescent 
microscope or with flow cytometry: this is called FISH 31. 
 
Intestinal commensal microflora and its interaction with the host 




growing interest in the interaction between the microflora and the host. Theoretically, there are 
several possible ways how this interaction takes place: (a) commensal bacteria may influence 
the mucosal immune system indirectly via uptake of whole bacteria or their fragments by either 
M cells, dendritic cells that send dendrites into the mucus layer, or via passive penetration of 
whole bacteria into the mucosa via incidental defects in the epithelial lining and mucus layer 
(e.g. due to a viral enterocolitis) 32, 33, (b) commensal bacteria may affect epithelial cells directly 
via epithelial Toll like receptors with affinity for bacterial cell wall components 34-36 or via small 
'soluble signals' that diffuse through the gelatinous mucus layer 37,38. Commensal bacteria that 
are responsible for the interaction with the host are expected to be in close vicinity with the 
epithelial cells and the mucosal immune system: these bacteria may be present within the 
mucus layer or be attached to epithelial cells. It is commonly believed that the composition of 
the bacterial microflora within the mucus layer differs from the microflora in the intestinal 
lumen 39, 40. An mucosa-adherent bacterial population, if it exists, should have the capability to 
attach to the mucus layer or to epithelial cells and multiply within the mucus and, thus, form 
microcolonies. In contrast, lumenal bacteria must be capable to multiply under the strict 
anaerobic conditions within the lumen and be able to degrade lumenal fibers and other 
remnants and use these as nutrients.  
 
Hypothesis for the pathogenesis of Crohn's disease 
IBD has a multifactoral origin. In the normal intestine a number of systems exist to avoid 
inflammation. There must be a redundancy of mechanisms so that failure of one mechanism is 
not enough to cause active inflammation. Therefore we hypothesize that IBD exacerbations 
may be the result of a 'two hit' process: (1) a temporary (lasting months or years) general loss 
of mucosal tolerance for luminal antigens (in the colon: anaerobic bacteria) together with (2) a 
temporary deficiency of either (a) the mucosal barrier function or (b) the capacity to remove 
antigens out of the mucosa without causing inflammation.  
 
Outline of this thesis 
The aim of this thesis is to investigate the interaction of the commensal colon microflora with 
the mucosal immune system in healthy subjects and patients with IBD. We particularly 
focussed on the humoral immune response. As a measure of the mucosal humoral immune 
response towards commensal colon bacteria we analysed fecal bacteria for the presence of 
immunoglobulins coated onto their surface. Presumably, most of these immunoglobulins are 
produced in the mucosa. A considerable percentage of the bacteria are not coated with 
immunoglobulins. For these bacteria, the mucosal immune system may be tolerant assuming 
that these bacteria have had ample time to come into contact with the immune system of the 
host. In chapter 2 we describe a newly developed flow cytometry method to analyse the 
presence of immunoglobulins on fecal bacteria. In chapter 3 fecal suspensions of 22 healthy 
volunteers were analysed and the percentage bacteria that were coated with IgA, IgG or IgM 
were determined. In chapter 4 this method was applied to fecal suspensions of patients with 
infectious colitis and IBD with various disease activity. Finally in chapter 5 this method was 
extended with double staining with fluorescent rRNA targeted probes (FISH) in order to 
determine whether certain bacteria are preferentially coated with immunoglobulins.  
Commensal bacteria that are responsible for the interaction with the host are expected to be in 
close vicinity with the epithelial cells and the mucosal immune system. However, it is not 
known whether these bacteria are present within the mucus layer or attached to epithelial cells. 
Furthermore, it is not known whether the composition of the bacterial microflora within the 
mucus layer differs from the composition of the microflora in the intestinal lumen (feces). With 
12
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FISH it is possible to specifically stain bacteria in biopsy sections. In chapter 6 we describe 
FISH of biopsies out of 6 different regions of the colon and terminal ileum of 9 healthy 
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Background. In the present study we describe a flow cytometry method for analysis of 
noncultured anaerobic bacteria present in human faecal suspensions. Non-bacterial faecal 
compounds, bacterial fragments and large aggregates could be discriminated from bacteria by 
staining with propidium iodide (PI) and setting a discriminator on PI-fluorescence and by 
exclusion of events with large forward scatter. Since anaerobic bacteria, which comprise over 
99.9% of all faecal bacteria, die during sample preparation, a fixation step was not necessary. 
A second aim of this study was to investigate the technical possibility of measurement of in 
vivo IgA coating of faecal anaerobic bacteria as well as their bacterial size.  
 
Methods. Faecal samples of 22 healthy human volunteers were analysed. The fluorescence 
distribution of IgA coated bacteria labeled with FITC-anti-Hu-IgA had overlap with 
noncoated bacteria. However, with match region subtraction, detection of low levels of 
specific FITC-fluorescence on IgA coated bacteria was achieved.  
 
Results. The median bacterial 2-dimensional surface area was 1.0 µm2. To validate flow 
cytometry data, all samples were analysed by an image analysis system as well.  
 
Conclusion. With this new method a rapid evaluation of faecal flora with high sensitivity for 
specific FITC-fluorescence is possible without culturing. 
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Flow cytometry offers a rapid method for the characterization of individual cells in mixed 
populations by physical and biochemical aspects. While major attention has been paid to 
measurement of eukaryotic cells, only some attempts have been made to analyse bacterial 
populations. In this field, the focus has been on bacterial pure cultures 1-5, though in some 
studies noncultured mixed bacterial populations like aquatic bacteria were characterised 6,7. 
Flow cytometry may be a potential technique to analyse faecal flora as well. However, no 
reports on this subject have been published yet. 
There is a growing interest in analysis and characterisation of the anaerobic intestinal flora. 
Faecal anaerobic bacteria may play a role in the pathogenesis of diseases like graft-versus-
host disease 8,9, inflammatory bowel disease 10,11 and bacterial cell wall induced arthritis in rats 
12
. Furthermore, intestinal anaerobic bacteria may inhibit colonisation of the intestinal tract by 
potentially pathogenic and pathogenic bacteria and therewith prevent infections 13.  
The human colon harbors about 1011 bacteria per gram contents. It is important to realise that 
over 99.9% of the colonic microflora consists of a stable ecosystem of possibly as many as 
400 different species of anaerobic bacteria in an individually characteristic composition 14-16. 
This composition may be influenced by IgA that is secreted in large amounts into the 
intestinal lumen. Potentially pathogenic aerobic bacteria like Enterobacteriaceae spp (e.g. 
Escherichia coli) comprise less than 0.1% of the colonic flora. 
Faecal anaerobic bacteria are difficult to study. Culturing and identifying anaerobic bacteria 
by biochemical properties is very time consuming. Moreover, for immunological studies, 
culture of bacteria may change their antigenic expression and harbors the danger of a bias 
towards easily culturable bacteria 14, 17-20. Therefore, we aim to examine noncultured human 
faecal anaerobic bacteria. A few years ago we have developed a phasecontrast-fluorescence 
microscope based computer image analysis system that enables us to record morphology and 
immuno-fluorescence labeling of each faecal bacterium separately 21-23. This image analysis 
method, however, is quite laborious.  
In the present study we describe a new rapid method to characterise the anaerobic faecal flora 
by flow cytometry. Faecal samples of 22 healthy human volunteers have been examined and 
forward scatter distributions are presented. Furthermore, we have determined the technical 
possibility of measurement of in vivo IgA coating of faecal anaerobic bacteria. To validate 





Materials and methods 
 
Volunteers 
Twenty two healthy volunteers, 13 male and 9 female, aged 21-61 years (median 32 years), 
provided a faecal sample. Exclusion criteria were: immunocompromised conditions 
(corticosteroids, diabetes, etc.), antibiotic use less than two weeks before sampling, diarrhoea 
and pregnancy. Each faecal sample was divided into 12 portions of 0.5 gram, frozen within 






Pure cultures: Pure cultures of human faeces derived Bacteroides fragilis, Fusobacterium spp., 
Clostridium difficile were grown under anaerobic circumstances in chopped meat 
carbohydrate. Pure cultures of human derived Escherichia coli, Klebsiella pneumoniae, 
Salmonella spp., Pseudomonas spp. were incubated in Brain Heart Infusion growth (BHI, 
Oxoid Hampshire, England). All strains were stored at -20°C until use.  
Reagents: Affinity-purified fluorescein isothiocyanate (FITC)-labeled goat F(ab’)2 anti-human 
IgA (F/P ratio = 2.0) from Kallestad (Austin, TX), FITC-labeled goat F(ab’)2 anti-mouse IgM 
(F/P ratio = 3.2) from Protos immunoresearch (San Francisco, Cal), BSA (fraction V) from 
Boehringer Mannheim (Mannheim, Germany), and propidium iodide (PI) from Sigma (St 
Louis, MO) were used. 
Study design: Faecal samples and suspensions of different pure cultured bacteria were 
analysed by flow cytometry as well as by image analysis. In vivo IgA coating of anaerobic 
bacteria was determined by staining faecal suspensions with FITC-F(ab’)2 anti-human IgA 
and subtraction of background-fluorescence as measured in nonstained suspensions. In order 
to determine the intra assay variation of measurement of bacterial in vivo IgA coating, 
replicate analyses of a single faecal sample were included in each series of measurements.  
 
Flow cytometry 
Flow cytometry was performed with an EPICS - ELITE (Coulter - Electronics, Hialeah, Fl). 
Sample excitation was done by an Argon laser operating at 15 mW and 488 nm. Filtersettings 
were 525 BP for FITC, 550 LP and 630 BP for measurement of PI. Acquisition and data 
analysis were done with standard ELITE software comprising the Immuno-4 program to 
determine the percentage of stained events. The flow cytometer was calibrated with 
Fluoresbrite plain microspheres (Polysciences, Inc., Warrington, PA) 0.72 µm in diameter, on 
forward scatter (FSC), side scatter (SSC) and FITC - fluorescence. Fluorescence quantitation 
was done with fluorescein quantitation kits (QuantumTM 24 and QuantumTM 25, from Flow 
Cytometry Standards Corp., NC, USA). To determine the level of background noise we used 
plain microspheres (Polysciences, Inc., Warrington, PA) 0.79 µm in diameter, which were 
assumed to have no fluorescence. For bacterial measurements the discriminator was set on 
propidium iodide (PI) fluorescence as a specific probe for bacteria. The discriminator value 
was determined by a filtered bacteria free (0.22 µm Millipore., Molsheim, France) solution of 
PI / PBS (4 mg/l) and set at a level with minimal background noise. For pure cultures of 
(larger) vital aerobic bacteria, a discriminator set on FSC was used and its value was 
determined with filtered PI / PBS (4 mg/l) at a level with minimal background noise.  
Actual analysis: Of each sample a portion incubated with PBS (background fluorescence) and 
a portion incubated with FITC-labeled goat F(ab’)2 anti-human IgA were analysed. Both 
measurements were performed with 10,000 events, at a flow rate of 1000 - 1500 events / sec. 
Data were stored in listmode on disc. The fluorescence was recorded logarithmically, FSC 
linearly. The mean fluorescence (logarithmic scale) was the fluorescence value corresponding 
with the calculated mean channelnumber (linear scale) of all events and was therefore not a 
true mean. Percentages of stained bacteria were determined with immuno-4 software 
(Coulter). 
Sorting experiments were performed with gates on FSC > 1000 and on FSC < 1000 in 
combination with gates on SSC or PI. Furthermore, a sorting experiment with a FSC - FITC 
fluorescence gate was performed to isolate a strongly IgA coated bacterial population. Sorted 
bacteria were collected on a slide and further evaluated by microscopy and computer image 
analysis. 
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Isolation and preparation of faecal bacteria for flow cytometry: Half a gram of faeces was 
suspended in 4.5 ml filtered (0.22 µm) PBS, homogenized on a Vortex mixer during 1 min. 
and centrifuged at low speed (35g, 20 min) to separate larger faecal particles from bacteria. 
Of each supernatant 20 µl (containing about 108 bacteria, as was determined by Direct 
Microscopic Clump Counts 29) was washed once in 1 ml of filtered PBS and centrifuged at 
8000g for 10 min to remove non-bound faecal IgA. The pellet was resuspended in 60 µl of 
BSA / PBS (1% w/v) or in FITC-labeled goat F(ab)2 anti-human IgA (1:100 in BSA / PBS 
(1% w/v)). Suspensions were incubated for 30 min at room temperature. One ml of PBS was 
added and mixed prior to centrifugation (8000g, 10 min). This wash procedure was repeated 
once. Finally, the bacterial pellet was resuspended in 500 µl PBS, added to 20 µl PI (4 mg/l 
(final concentration) was found to be optimal), stored on ice in the dark and analysed within 
two hours. 
In order to determine the specificity of the FITC-F(ab’)2 goat anti-Hu-IgA, a FITC-F(ab’)2 
goat anti-mouse-IgM was added to human faecal bacterial suspensions. Further processing 
was identical to the procedure described above. 
Preparation of pure cultured bacteria for flow cytometry: Pure cultured bacteria were washed 
once with PBS, adjusted to the optimal bacterial concentration (108 bacteria / ml) in 500 µl, 
added to 20 µl PI (final concentration: 4 mg / l), stored on ice in the dark and analysed within 
two hours. For vital pure cultured aerobic bacteria the discriminator was set on FSC. Special 
precautions were taken to prevent environmental contamination by these bacteria. 
 
Computer image analysis 
The instrumentation has been described in detail elsewhere 1, 29. Briefly, we used a microscope 
equipped with a phase-contrast, mercury vapor lamp and a BP490 filter block (transmission of 
490 - 750 nm). A high resolution CCD video camera was mounted on top of the microscope 
and connected with a computer. An exposure-control expansion board enabled us to record 
long-exposure images (4 sec.). Fluorescence measured by each pixel of the video camera was 
calibrated using a uniformly fluorescent uranyl glass slide (Schott, Mainz, Germany) and was 
therefore expressed in uranyl units (uU). Fluorescence quantification was done with 
fluorescein quantitation kits (QuantumTM 24 and QuantumTM 25). A 2D-surface area 
threshold was set on 0.15 µm2, i.e. small objects not believed to be bacteria. To record the 
fluorescence of each object in the microscopic field of view, it is necessary to acquire two 
images (a) with morphological information (phasecontrast), and (b) with fluorescence 
information. For each object, the average level of fluorescence within the object as well as its 
exact morphology and surface area were computed. All measurements were performed with at 
least 1000 objects per sample and the median and third quartile of fluorescence as well as the 
median bacterial surface area were determined. 
Isolation and preparation of faecal bacteria for image processing: The procedure is in part 
analogous to the sample preparation procedure used for flow cytometry 1. Half a gram of 
faeces was suspended in 4.5 ml of demineralised water, homogenized on a Vortex mixer 
during 1 min. and centrifuged at low speed (35g, 20 min). The bacteria in the supernatant 
were diluted to a 2% suspension in demineralised water with 0.5% Tween 80 (Merck, 
Germany) and 10 µl was pipetted into a well of three different degreased twelve well slides 
(Immunocor, France) which previously had been coated with a 10% poly-l-lysine solution 
(Sigma Diagnostics, St. Louis., USA) in order to ensure optimal adhesion of the faecal 
bacteria to the slide. After drying and fixation in acetone during 10 min, gentle washing (PBS, 
5 min) and again drying, slides were stored at -20°C before use. After thawing, 20 µl of 
FITC-labeled goat F(ab’)2 anti-human IgA (1% (v/v) in BSA / PBS (1% w/v)) or 20 µl of 
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BSA / PBS (1% w/v), was pipetted into each well. After incubation for 30 min in a moist 
chamber at 20°C in the dark, slides were washed gently three times in PBS, embedded in 
mounting fluid (glycerol / Tris buffer v/v 1:1), covered with a coverslide and stored in a moist 
chamber at 4°C in the dark for at least 2 h and max. 72 h. A third slide was stained with PI 
(20 µl, 100 mg / l PBS) and analysed within two hours. Pure cultured bacteria were processed 




Spearman rank correlation coefficients were computed to determine the relations between 
variables of fluorescence, FSC and surface area. Two tailed probabilities are presented. 
Simple linear regression analysis was performed in order to determine the best fitted line 
between variables. The coefficient of variation of six separate analyses of one faecal sample 
























Figure 1. Relation between median 2D-surface area (image analysis) and mean forward scatter (flow 
cytometry) for pure cultures (closed circles, n=7) and faecal samples (open circles, n=22). Pure 
cultured bacteria, ordered according to their surface area (smallest surface area first), were 
Pseudomonas spp., Bacillus fragilis, Fusobacterium spp., Salmonella spp., Klebsiella spp., Clostridium 
perfringens and Escherichia coli. For pure culture data, the best fitted line as calculated by linear 
regression analysis is shown. 
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Bacterial size calibration 
In flow cytometry forward scatter (FSC) corresponds to cell-volume 6, 24. However, with image 
analysis the 2 Dimensional (2D) surface area of recorded bacteria is determined. Therefore, 
we determined the relation between FSC and 2D-bacterial surface area by measurement of 
seven pure cultures of human faeces derived aerobic and anaerobic bacteria with flow 
cytometry and image analysis. There was a considerable variation in FSC within a pure 
culture (coefficient of variation, CV = 35-100%). However, FSC-mean and surface area-
median were correlated (ρ = 0.964, p < 0.01, fig 1). The smallest bacterial species measured, a 
Pseudomonas spp., had a median surface area of 0.55 µm 2 and a mean FSC of 23. 
 
Fluorescence quantitation 
We aimed to attribute Molecules of Equivalent Soluble Fluorochrome (MESF) values to the 
FITC-fluorescence as measured by flow cytometry 25. Hence we analysed by logarithmic 
recording, latexparticles with defined MESF values as well as ‘non-fluorescent’ particles of 
various sizes (8.6 µm, 6 µm, 0.79 µm). FITC- fluorescence values were linearly correlated 
with MESF values (fig 2, r=0.975, p=0.0001). Logarithmic fluorescence recording tends to be 
less accurate than linear recording at very high or low fluorescence values. Since for bacterial 
analysis we use logarithmic fluorescence recording, we intended to quantify this inaccuracy 
by analysis of the latexparticles with both types of recording. Logarithmically and linearly 
recorded fluorescence values were similar for all fluorescent particles (r=1.0, p=0.0001). 
However, many faecal anaerobic bacteria have very low fluorescence and there are no 
calibration particles with such low MESF values. Therefore, we analysed ‘nonfluorescent’ 
particles of different sizes as well by both types of recording and their ‘fluorescence’ 
increased with their size. Assuming that the measured linear mean in this regions with 
extremely low fluorescence is still accurate, we extrapolated the relation between linearly 
recorded FITC-fluorescence of nonfluorescent latexparticles and MESF (fig 2). The 
extrapolated fluorescence values of the two smallest particles were 120 MESF and 250 
MESF. At these extremely low fluorescence values, logarithmically recorded ‘fluorescence’ 
was 50 % lower than linearly recorded fluorescence (fig 2). This suggests that as few as about 
300 FITC molecules can be detected by logarithmic recording.  
 
 
Figure 2. Relation between MESF and 
fluorescence as determined by both 
logarithmically and linearly recording of 
FITC-fluorescence quantitation particles 
by flow cytometry (closed circles, only 
linearly recorded data are visualised). 
The best fitted line as calculated by linear 
regression analysis is shown. MESF 
values of linearly recorded 
nonfluorescent particles were 
extrapolated assuming that the 
photomultiplier was perfectly linear in 
this fluorescence region (continuous 
line). Extrapolated MESF values of 
logarithmically recorded nonfluorescent 
particles were determined with respect to 




In order to attribute MESF to fluorescence values determined by image analysis, fluorescein 
quantitation particles were measured by image analysis as well. Fluorescence recorded by our 
image analysis system is expressed in uranyl units (Uu), i.e fluorescence per µm 2. Therefore, 
MESF values were corrected for the calculated 2D-surface area of the particles. These 
corrected MESF values were linearly correlated with the fluorescence expressed in uU (1 uU 
= 34x103 MESF / µm 2). 
 
Elimination of large aggregates 
Faecal suspensions contain large particles, apart from single bacteria. Despite low speed 
centrifugation during sample preparation, large particles were still observed during flow 
cytometry measurement. In order to determine the FSC above which no single bacteria were 
present, the 2D-surface area of faecal bacteria present in samples of 22 healthy human 
volunteers were measured with computer image analysis. Objects with a 2D-surface area 
larger than 5 µm 2 (less than 1% of all objects since only images with few aggregates were 
recorded) were nearly all composed of aggregated bacteria (data not shown). Extrapolation of 
the relation between surface area and FSC shows that 5 µm 2 corresponds with FSC = 1000 
(fig 1). Therefore, all further flow cytometry analysis were performed with a gate set on FSC 
< 1000. Therewith 6% of the events were excluded. In order to check whether events with 
FSC > 1000 were aggregates, a sorting experiment was performed with a gate on FSC > 1000. 
Sorted objects visually evaluated by phasecontrast microscopy, all appeared to be aggregates. 
However, 8% of all objects with a surface area < 5 µm 2 appeared to be aggregates of smaller 
bacteria and could therefore not be excluded by criteria based on bacterial size. 
A possible relation between side scatter (SSC) and bacterial morphology was investigated by 
flow cytometry sorting of bacteria with high SSC. Visual evaluation of the sorted events by 
phasecontrast microscopy showed that events with very high SSC were bacteria with an 




















Figure 3. Typical forward scatter (FSC) versus propidium iodide (PI) fluorescence distribution of a PI-
stained faeces derived bacterial suspension. A  discriminator was set on PI-fluorescence (3a) or FSC 
(3b) at a level with minimal background noise. 
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Only Propidium Iodide positive events were analysed by flow cytometry 
For flow cytometry analysis of eukaryotic cells, a discriminator is usually set on FSC. 
However, the FSC of a proportion of faecal bacteria is too low to be analysed with a 
discriminator set on low FSC (fig 3ab). We therefore stained all faecal bacterial suspensions 
with propidium iodide (PI), a fluorescent stain for double stranded DNA / RNA. Since 
anaerobic bacteria will have died during our sample preparation procedure, they have become 
permeable for PI. With a discriminator set on PI-fluorescence it was possible to analyse 
events with very low FSC (fig 3a).  
A second advantage of a discriminator set on PI-fluorescence is exclusion of PI- non-bacterial 
compounds (e.g. cellular debris, mucus) and bacterial fragments present in washed faecal 
bacterial suspensions. To make sure that the excluded PI- events were indeed fragments or 
objects of non-bacterial origin, their morphology was determined by flow cytometry sorting 
(with a discriminator set on FSC). Only a small proportion (20%) of all events was PI- (fig 
3b). Visual evaluation of the sorted PI- events by phasecontrast microscopy was performed. 
Besides large amounts of small objects, presumably bacterial fragments, irregular clearly non-
bacterial objects (presumably mucus fragments and undigested dietary compounds) were 
seen.  
A second experiment to determine the morphology of PI- objects was performed by image 
analysis of PI stained slides with bacterial suspensions of all faecal samples. The PI-
fluorescence distribution showed a distinct non-stained peak (PI-). The median percentage PI- 
objects was 40% (range 22-65%) with a median 2D-surface area of 0.46 µm 2. With this 
image analysis system it is possible to plot bacteria according to two independent morphology 
variables (1). Morphologically, PI- objects were largely concentrated in the region of small 
coccoid objects which was scarcely populated by PI+ objects. With our image analysis system 
it is not yet possible to measure FITC at the same time as PI. In order to eliminate many PI- 
objects from further analysis by image analysis software, we excluded all small coccoid 
objects (18%, of which were 80% PI-) by morphological criteria. The median percentage PI- 
objects remaining was 28%. 
 
Size of faecal anaerobic bacteria  
Faecal bacteria form a morphological heterogenous population. In order to determine the 
normal variation in distribution of faecal bacterial size, we analysed faecal bacterial 
suspensions of 22 healthy human volunteers both by flow cytometry and image analysis. 
There was a considerable variation of FSC within samples as expressed by a CV of 110-159% 
(fig 3). The median FSC of all samples was 129 (range 79-183) corresponding with a 2D-
surface area of 1.0 µm2 (fig 1). The mean FSC intra-assay CV (9%) was lower than the mean 
FSC CV of all samples (19 %). Most (80%) PI+ events had a FSC < 200, corresponding with 
a 2D-surface area of < 1.5 µm2. 
For determination of the median bacterial 2D-surface area, PI stained slides were measured by 
image analysis and PI+ objects were evaluated. The median bacterial 2D-surface area of all 
faecal samples was 1.07 µm2 (range 0.78 - 1.30, CV = 11%). Of each sample about 80% of 
the PI+ objects had a surface area < 1.5 µm 2 which is comparable to flow cytometry. 
The correlation between median bacterial 2D-surface area and mean FSC of all samples was 



























Figure 4. Typical example of fluorescence distributions of nonstained bacteria (overlay, continuous 
line) and bacteria labeled with FITC-anti-IgA (dotted line) as recorded by flow cytometry. The 
fluorescence histogram of nonstained bacteria was matched with the histogram of stained bacteria and 
subtracted by match region subtraction. The matched region (A), the region in which the percentage of 
stained bacteria is calculated (C) and the resulting fluorescence histogram (overlay) are shown. 
 
In vivo IgA coating of faecal anaerobic bacteria  
One of the aims of this study was to analyse the technical possibility of measurement of in 
vivo IgA coating of anaerobic bacteria present in faecal suspensions by flow cytometry. 
Therefore, we analysed faecal bacterial suspensions stained with FITC-F(ab’)2 anti-Hu-IgA as 
well as nonstained samples by flow cytometry. All samples were stained with PI as well, and 
the discriminator was set on PI fluorescence. 
Fluorescence of nonstained bacteria as measured with FITC-filtersettings, was only present in 
the lower channels (fig 4). The fluorescence distributions of the nonstained samples (n=22) 
were similar with a median value of 0.24 (range 0.17 - 0.27, CV = 6%) corresponding with 
2x102 MESF. To determine the contribution of photomultiplier background noise to these 
extremely low fluorescence values, we analysed nonfluorescent latex-particles of bacterial 
size (0.79 µm). Their mean fluorescence value was 0.142 and their fluorescence distribution 
was smaller than that of all nonstained faecal suspensions. To determine the specificity of the 
measurement of ’in vivo’ IgA coating of faecal bacteria, faecal samples were stained with a 
nonsense FITC-F(ab’)2-anti-mouse IgM. No nonspecific staining was detected. 
All samples were found to contain IgA coated bacteria and there was not a clear 
discrimination between fluorescence values of stained and nonstained bacteria (fig 4). 
However, in one sample a separate strongly IgA coated bacterial population was seen (fig 
5). In order to estimate the percentage of faecal bacteria coated with IgA and their levels of 
fluorescence we performed match region subtraction (26) by immuno-4 software. With this 
method a fluorescence histogram of nonstained bacteria is matched over a region (match 
region) with the corresponding histogram of stained bacteria, its heighth (size) adjusted and  
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Figure 5. FSC versus FITC-fluorescence distribution of 
a faecal bacterial suspension stained for IgA. This 
sample contained a separate strongly IgA coated 












thereafter both are subtracted (fig 4). The median percentage of stained bacteria was 45 % 
(range 24 - 74, CV = 28 %) and their median fluorescence value was 2.33 (range 0.99 - 
4.74, CV = 38 %) corresponding with 1300 MESF. The intra-assay variations were 9 % 
(percentage of stained bacteria) and 7 % (mean fluorescence value). Within the samples 
there was not a clear relation between FSC and fluorescence of bacteria labeled with FITC-
anti-IgA (fig 4). Neither was there a relation between the mean FSC and the percentage of 
stained bacteria of all samples, nor between the mean FSC and the mean specific 
fluorescence. 
In order to validate flow cytometry data, all faecal samples were analysed by image analysis 
as well. Since total numbers of bacteria recorded by image analysis were low and no 
histogram subtraction software was available, only the median and third quartile (Q3) of 
fluorescence were calculated. The median of all median fluorescence values of nonstained 
samples was 0.015 uU (range 0.008 - 0.023, CV = 26%) corresponding with 5 x 102 MESF / 
µm2. For the Q3 of fluorescence the median value was 0.022 uU. Also with image analysis all 
samples were found to contain IgA coated objects and there was not a clear discrimination 
between fluorescence distributions of stained and nonstained objects. In order to estimate the 
specific fluorescence (i.e. fluorescence due to labeling with FITC-anti-IgA) of each sample, 
the median (and Q3 of) fluorescence of nonstained bacteria was subtracted from the median 
(and Q3 of) fluorescence of stained bacteria. For all samples the median specific fluorescence 
was 0.011 uU (range 0.002 - 0.025, CV = 43%) corresponding with 4 x 102 MESF / µm 2. 
The median value of all Q3 of specific fluorescence was 0.029 uU. 
Fluorescence data of bacteria labeled with FITC-anti-IgA obtained by both methods were 
correlated. The mean fluorescence of stained bacteria as determined by flow cytometry 
correlated significantly with the Q3 of specific fluorescence obtained by image analysis (ρ = 
0.54, P < 0.05 , fig 6). In contrast with the Q3, the median specific fluorescence (image 
analysis) did not correlate with flow cytometry data. 
Strongly fluorescent bacteria within a mixed population like faecal flora should be recognised 
by both systems. Fortunately, one faecal sample contained a separate small population (2%) 
of strongly FITC-anti-IgA labeled bacteria with a mean FSC of 180 (fig 5). Morphology of 
these bacteria was determined by image analysis as well as by flow cytometry sorting. The 
most fluorescent bacteria recorded by image analysis were coccoid rods with a median 
surface area of 1.3 µm 2. Flow cytometry sorted bacteria were visually evaluated and were 






















Figure 6. Relation between fluorescence values of bacteria labeled with FITC-anti-IgA of 22 human 
faecal samples as determined by both methods. MESF values corresponding with the third quartile of 
specific fluorescence (image analysis) and the mean fluorescence of stained bacteria as determined 







Flow cytometry analysis of noncultured faecal anaerobic bacteria. 
In the present study we describe a new rapid flow cytometry based method to analyse 
noncultured anaerobic bacteria present in human faecal suspensions. Major problems in our 
approach appeared to be the small size of some faecal bacteria, the presence of non-bacterial 
objects and bacterial fragments as well as the presence larger objects formed by bacterial 
aggregates. Since aerobic bacteria comprise less than 0.1 % of the faecal flora, their 
contribution to the data will be negligible 16. 
A discriminator set on FSC, as is commonly used for eukaryotic analysis, is sufficient to 
analyse suspensions of larger bacteria without interference of background noise 1, 2, 4, 27. Our 
faecal bacterial suspensions, however, appeared to contain small bacteria as well, with a FSC 
at a level at which background noise is present. As was described by others for aerobic 
bacteria 7, 28, we show here that with a trigger set on propidium iodide (PI) staining, small intact 
anaerobic bacteria can be selectively analysed without interference of background noise. In 
contrast to aerobic bacteria which need some kind of fixation to become killed and permeable 
for the fluorescent dsDNA / RNA stain PI, anaerobic faecal bacteria stain with PI without 
other treatment than exposure to oxygen during sample preparation. The absence of PI- 
objects with bacterial morphology supports this statement. 
A second advantage of a discriminator set on PI-fluorescence is exclusion of PI- non-bacterial 
objects. A characteristic of most small non-bacterial faecal compounds (e.g. cellular debris, 
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mucus) and bacterial fragments is that they do not contain dsDNA or RNA and therefore will 
not stain with PI. Our results show that the discarded PI- events were indeed non-bacterial 
compounds and bacterial fragments. 
Faecal bacterial suspensions contain large particles, apart from single bacteria. However, 
despite low speed centrifugation during sample preparation, large particles were still observed 
during flow cytometry analysis. For this reason we used size as an additional selection 
criterion. With a gate on FSC < 1000 all single bacteria were analysed. However, 8% of all 
particles with a FSC < 1000 were agglutinated small bacteria. 
In conclusion, with a discriminator set on PI-fluorescence and exclusion of events with high 
FSC, most if not all analysed events are intact predominantly single faecal anaerobic bacteria. 
 
Size of anaerobic faecal bacteria. 
To our knowledge, no data on the size of bacteria present in faecal suspensions have been 
published yet. Therefore, faecal samples of 22 healthy volunteers were analysed by flow 
cytometry and data were validated by analysis of the same samples by computer image 
analysis as well. Faecal flora consists of a heterogenous population of possibly as many as 
400 different species of anaerobic bacteria 15. In faecal suspensions each species is present in 
low concentrations of < 3 % 14 This heterogeneity was reflected in the large coefficient of 
variation (CV) of the FSC distributions within a sample, compared to pure cultures. The 
majority of the analysed faecal bacteria were small, with a FSC corresponding with a 2D-
surface area < 1.5 µm 2. This surface area is smaller than that of pure cultures studied of E.coli 
or Klebsiella spp., but larger than that of Pseudomonas spp. There was an interindividual 
variation in mean FSC (CV = 19 %). However, since no longitudinal study was performed, it 
is not possible to ascribe this interindividual variation in FSC to stable interindividual 
differences in faecal flora composition for which some evidence is found in the literature 14, 16. 
In conclusion, faecal suspensions contain a heterogenous bacterial population with large 
variation in bacterial size. However, most faecal bacteria are small with a 2D-surface area < 
1.5 µm 2. 
 
Quantitation of low FITC fluorescence values. 
FITC-Fluorescence as measured with flow cytometry was quantitated with fluorescein coated 
particles in Molecules of Equivalent Soluble Fluorochrome (MESF) and there was an 
excellent linear correlation between MESF and FITC-fluorescence. In order to attribute 
MESF to the fluorescence levels comparable to those of anaerobic bacteria labeled with 
FITC-anti-IgA, we had to extrapolate the linear relation between MESF measured FITC 
fluorescence of ‘nonfluorescent’ latexparticles. Herewith, the lower detection limit of 
logarithmicly recorded fluorescence of our flow cytometer was found to be as low as 3x102 
MESF, assuming that the photomultiplier was perfectly linear in this fluorescence region. 
Deviations from linearity will cause an increase in this MESF value. 
 
In vivo IgA coating of faecal anaerobic bacteria. 
One of the aims of this study was to determine the technical possibility of measurement of in 
vivo IgA coating of anaerobic bacteria present in faecal suspensions by flow cytometry. In the 
gut lumen, IgA is secreted by the intestinal mucosa in large amounts and specificity for 
intestinal anaerobic bacteria is present 10. All faecal samples were found to contain IgA coated 
as well as non-IgA coated bacteria. The mean fluorescence of non-IgA coated bacteria was 2 




In most samples there was not a clear discrimination between fluorescence distributions of 
stained and nonstained bacteria. For this reason we performed match region subtraction by 
which fluorescence histograms of nonstained samples are matched over a region with 
histograms of corresponding stained samples and subtracted. This subtraction method was 
found to be very accurate for analysis of overlapping distributions of stained and control 
samples, compared to simple subtraction or threshold analysis, and nearly as good as curve 
fitting 26. The median percentage of IgA coated bacteria was 45 % with a mean fluorescence of 
1300 MESF. However, the ‘mean’ of logarithmic recorded parameters as presented by ELITE 
software is not a true mean. The mean channel number of all events is determined and the 
corresponding parameter LOG value is calculated and presented as the ‘mean’. This ‘mean’ 
will be lower than the true mean. An advantage is, however, that the ‘mean’ will be more 
robust and therefore less susceptible to small changes of events with high parameter values. 
Amplification of the staining signal, by for instance biotin labeling of the anti-IgA polyclonal, 
is a second approach to increase the sensitivity of estimation of the percentage of stained 
bacteria. However, this was beyond the scope of this study. 
In order to validate measurement of in vivo IgA coating by flow cytometry, we determined in 
vivo IgA coating with computer image analysis as well. There was a significant correlation 
between the mean fluorescence (flow cytometry) of bacteria labeled with FITC-anti-IgA and 
the third quartile of specific fluorescence as recorded by image analysis. The absence of a 
correlation between the median of specific fluorescence (image analysis) and flow cytometry 
data is probably partly due to a larger relative contribution of the autofluorescence to image 
analysis data due to less selective fluorescence filters. These increased autofluorescence 
values resulted in a decreased relative difference between the median fluorescence of 
nonstained bacteria (autofluorescence) and the median fluorescence of bacteria labeled with 
FITC-anti-IgA and therefore a larger influence of statistical variation. Furthermore, a 
considerable but variable percentage of the image analysis data consisted of PI- objects. 
Finally, the ‘mean’ as presented by ELITE software is presumably more approximate to the 
third quartile than to the median value. In conclusion, with flow cytometry it is possible to 
measure in vivo IgA coating present on faecal bacteria with high sensitivity. 
 
Comparison of flow cytometry with image analysis 
In order to compare flow cytometry with our image analysis system 21, 22, analogous parameters 
of bacterial size and fluorescence were measured of pure cultures and all 22 human faecal 
samples. In contrast with flow cytometry, with our image analysis system it is not yet possible 
to measure two different fluorescent stains at the same time, i.e. FITC together with PI. 
Consequently, PI- objects could only be partially eliminated from further evaluation by 
morphological criteria. We found a linear relation between FSC and bacterial 2D-surface area 
as was determined with analysis of several pure cultures by flow cytometry as well as image 
analysis. Robertson et. al. however, found a linear relation between FSC and bacterial volume 
6
. Presumably, in this small 2D-surface area region there is an approximately linear relation 
between bacterial 2D-surface area and bacterial cell volume.  
In contrast with flow cytometry, image analysis records morphology in addition to bacterial 
size. Furthermore, the threshold for accurate measurement of bacterial size is lower for image 
analysis (0.15 µm 2) than for flow cytometry (0.5 µm 2). However, flow cytometry acquisition 
rate is 1,000 x higher compared to image analysis. Flow cytometry, furthermore, was more 
effective in the reduction of autofluorescence, could effectively eliminate PI- events and 
offered match region subtraction software. For these reasons, flow cytometry was more 
sensitive for measurement of low levels of FITC-fluorescence than image analysis. 
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Nevertheless, as discussed above there was a significant correlation between specific 
fluorescence values as determined by both methods. Further evidence for a comparable 
determination of higher levels of specific fluorescence on bacteria was obtained by analysis of 
the morphology of a small population of strongly FITC-anti-IgA labeled bacteria by both 
methods. Visual evaluation of this population obtained by flow cytometry sorting revealed a 




In conclusion, with flow cytometry it is possible to analyse intact single faecal bacteria within 
highly heterogeneous bacterial populations and without interference of contaminating non-
bacterial compounds, bacterial fragments and aggregates. Furthermore, it is possible to 
measure low levels of bacterial in vivo IgA coating by means of immuno-fluorescence.   
In comparison with image analysis, flow cytometry is more sensitive for measurement of low 
levels of specific fluorescence and has a very high acquisition rate. However, image analysis 
records bacterial morphology and has a lower 2D-surface area threshold. Despite these 
differences, parameters of bacterial size and specific fluorescence as measured by both 
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Background. The bacterial flora in the human colon, though extremely diverse, has a relative 
stable composition and non-infectious anaerobic bacteria are dominant. The flora forms a pool 
of numerous different antigens separated from mucosal immunocompetent cells by just a single 
layer of epithelial cells. However, despite this thin barrier, the colonic mucosa is 
physiologically only mildly inflamed. Here, we studied the mucosal humoral immune response 
against fecal anaerobes.  
 
Methods. By flow cytometric analysis the in vivo immunoglobulin coating of anaerobic 
bacteria in fecal samples of 22 healthy human volunteers was determined. In a previous study 
flow cytometric analysis of fecal bacteria has been found to be a very sensitive method to 
detect immunoglobulins on fecal bacteria.  
 
Results. With this technique we show that in vivo many bacteria are coated with IgA (24-74%) 
and less with IgG and IgM.  
 
Conclusions. The presence of many bacteria coated with IgA implies that IgA coating does not 
result in permanent removal of the species from the colon. On the other hand, the absence of 
immunoglobulin coating makes immunological non-responsiveness for anaerobic bacterial 
antigens likely. In this article we hypothesize that both immunological non-responsiveness and 
preferential coating with IgA are responsible for the relative absence of colonic mucosal 
inflammation. 
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Introduction 
 
Antigens, both of dietary and bacterial origin, are abundantly present in the colonic lumen. 
Bacterial antigens predominate since there are as many as 1011 bacteria per gram contents 
while most dietary antigens are degraded. It is important to realise that over 99.9% of the 
colonic microflora are part of a relatively stable ecosystem consisting of possibly as many as 
400 different indigenous species as well as few recently arrived species. The great majority of 
these anaerobic bacteria are non-infectious and each human individual has a characteristic 
combination of these microorganisms 1 - 3. Potentially pathogenic aerobic Enterobacteriaceae spp 
(like Escherichia coli) comprise less than 0.1% of the colonic flora. In order to colonize and 
multiply within the mucus layer (mucus flora), bacteria must somehow anchor in the mucus 
layer or attach to the epithelial cells. From the mucus layer they may continuously seed into the 
colonic lumenal contents where they continue to multiply and form the lumenal (fecal) flora.  
In the colon the mucosal immune system consists of many lymphocytes, phagocytes and 
predominantly IgA secreting plasma cells. These immunocompetent cells are separated from 
large amounts of different antigens present in the mucus layer and the colonic lumen by just a 
single layer of epithelial cells. However, the colonic mucosa is only mildly inflamed despite 
continuous translocation of (bacterial) antigens through this epithelial barrier 4. A better 
understanding of the mechanisms that are responsible for the prevention of mucosal 
inflammation might give a clue for the pathogenesis of inflammatory bowel disease.  
Two mechanisms may be important: 1. Mucosal non-responsiveness to antigens of anaerobic 
bacteria, i.e. absence of a mucosal immune response 1 - 3, 5 - 8 and, 2. Prevention of inflammation 
by the secretion of specific non-complement binding secretory IgA (sIgA) 9. Extremely little is 
known about the interaction between the anaerobic colon flora and the mucosal immune system 
10
. This is due to both the difficulties associated with culturing anaerobic bacteria and the 
absence of sensitive methods to analyse this interaction. Recently we developed a flow 
cytometric method with which low levels of immunoglobulin (Ig) coating (hundreds of 
molecules) on anaerobic bacteria in fecal suspensions can be determined with great accuracy 11.  
In this study we analysed the in vivo immunoglobulin coating of fecal anaerobic bacteria in 
man by flow cytometry. We show that many fecal anaerobic bacteria are coated with IgA, 





Materials and methods 
 
Volunteers and sampling 
Twenty two healthy volunteers, 13 male and 9 female, aged 21-61 years (median 32 years), 
provided a fresh fecal sample. Exclusion criteria were: immunocompromised conditions, IgA 
deficiency, antibiotic use less than two weeks before sampling, diarrhea and recent change in 
bowel habits. Each fecal sample was divided into portions of 0.5 gram, frozen within three 
hours after voiding and stored until use at -20°C. 
 
Laboratory analysis 
Reagents: Affinity-purified polyclonal fluorescein isothiocyanate (FITC)-labelled goat F(ab’)2 
anti-human IgA, IgG, IgM (F/P ratios 2.0, Kallestad, Austin, TX), Bovine serum albumin 
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(BSA, fraction V, Boehringer Mannheim, Mannheim, Germany), and propidium iodide (Sigma, 
St Louis, MO) were used. 
Study design: Suspensions of fecal samples were analyzed by flow cytometry 11. In vivo IgA, 
IgG and IgM coating of anaerobic bacteria was determined by staining fecal suspensions with 
FITC-F(ab’)2 anti-human IgA, IgG or IgM and subtraction of background-fluorescence as 
measured in nonstained suspensions (12). 
Flow cytometry : Flow cytometry was performed as was described in detail previously 11. 
Briefly, an EPICS - ELITE (Coulter - Electronics, Hialeah, Fl) equipped with an Argon laser 
operating at 15 mW and 488 nm was used. Filter settings were 525 BP for FITC, 550 LP and 
630 BP for measurement of PI. Calibrations were done with Fluoresbrite plain microspheres 
(Polysciences, Inc., Warrington, PA) 0.72 µm in diameter, on forward scatter (FSC), side 
scatter and FITC - fluorescence. Measurements were performed on 10,000 events, at a flow rate 
of 1000 - 1500 events / sec. The FITC - fluorescence was recorded logarithmically and 
fluorescence values were transformed into Molecules of Equivalent Soluble Fluorochrome 
(MESF). All events that stained with propidium iodide (PI) were regarded as bacteria and 
therefore, the discriminator was set on PI - fluorescence. An additional gate was set to exclude 
events with very large FSC (agglutinated bacteria). Analysis was done with standard ELITE 
software comprising the Immuno-4 program to determine the percentage of stained events by 
match region subtraction 12. The matched region ranged 10 - 80 units (of a total region of 1024) 
for the samples stained for IgA, IgG and some stained for IgM. For samples stained for IgM 
with very low and intermediate specific fluorescence, the matched region ranged 10-170 units. 
A second analysis was performed by simple threshold analysis. The threshold was set at 2100 
MESF. 
Sample preparation: Half a gram of feces was suspended in 4.5 ml bacteria free PBS, 
homogenized on a Vortex mixer and centrifuged at low speed to separate larger fecal particles 
from bacteria. Samples containing about 108 bacteria (20 µl supernatant) were washed once in 
1 ml of filtered PBS and centrifuged at 8000g for 10 min to remove non-bound fecal - Ig. The 
pellet was resuspended in 60 µl of BSA / PBS (1% (w/v)) as well as in FITC-labelled F(ab)2 
anti-Hu IgA, IgG or IgM (1% in BSA / PBS (1% (w/v)). After a 30 min incubation period, 
suspensions were washed twice with PBS. Finally, the bacterial pellet was resuspended 
(Vortex) in 500 µl PBS, mixed with 20 µl PI (100 mg / l), stored on ice in the dark and 
analysed within two hours. 
Mucus flocks: All fecal samples were found to contain a number of small mucus flocks which 
were densely packed with bacteria believed to represent the flora of the mucus layer (mucus 
flora). In order to analyse these flocks, three slides were prepared of each fecal suspension and 
sample preparation was essentially analogous to the procedure used for flow cytometry 11, 13. 
Briefly, for each sample half a gram of feces was suspended in 4.5 ml bacteria free PBS and 
homogenized on a Vortex mixer. The fecal suspensions were diluted to 2% in demineralized 
water with 0.5% Tween 80 (v/v) (Merck) and 10 µl was pipetted into a well of three different 
degreased twelve well slides (Immunocor, France). After drying, fixation (acetone, 10 min), 
gentle washing in PBS and again drying, slides were stored (-20°C) until use.  
After thawing, one of each set of slides was stained with FITC-labelled goat F(ab’)2 anti-human 
IgA, washed gently three times for 10 sec in PBS, imbedded in mounting fluid (glycerol / Tris 
buffer v/v 1:1) and stored in a moist chamber at 4°C in the dark. A second slide was not stained 
to analyse background fluorescence. The remaining slides were stained with the mucus stain 
alcian blue (routinely performed in the Pathology department in the Academic Hospital of 
Groningen, Dr. W. Timens).  
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Results 
 
In vivo coating with IgA 
In a previous study, we have shown that immuno-fluorescence combined with flow cytometry 
is a very rapid and sensitive method to analyse Ig-coating of noncultured anaerobic fecal 
bacteria. With this method, even a few hundred molecules of Ig per bacterium can be detected 
11
. Here we use this method to determine the in vivo IgA coating of anaerobic bacteria in feces. 
Fecal suspensions of 22 human volunteers were incubated with FITC conjugated affinity 
purified polyclonal F(ab’)2 anti human IgA. In fig 1 we show an example of fluorescence 
histograms of both anti-IgA stained and nonstained bacteria. Since both histograms show 
considerable overlap, an advanced histogram subtraction method was used to determine the 
percentage of stained bacteria as well as their mean fluorescence. With match region 
subtraction, histograms of nonstained samples are matched over a region with histograms of 
corresponding stained samples and subtracted (fig 1). This subtraction method was found to be 
more accurate for analysis of overlapping distributions of stained and control samples, 






















Figure 1. Histograms with typical FITC-fluorescence distributions of 10,000 fecal bacteria stained with 
FITC-anti Hu IgA (dotted line) or nonstained (continuous line) as analysed by flow cytometry. In order 
to compute the percentage of bacteria coated with IgA, match region subtraction was performed (left 
histogram, immuno-4 software 11, 12). Hereby, the histogram of nonstained bacteria is matched over a 
region (match region, A) with the corresponding histogram of stained bacteria, its height (size) adjusted 
and thereafter both are subtracted. The resulting histogram shows the bacteria coated with IgA (right 
histogram). The percentage IgA coated bacteria is calculated over region C. FITC - fluorescence values 




In our samples analysed, a variable proportion of bacteria was coated with IgA (fig 1). Of all 
bacteria in a sample 24 - 74 % (median 45 %) were labelled with FITC anti-IgA (fig 2a). In 
order to quantify the amount of IgA on the bacteria, we determined mean values of Molecules 
of Equivalent Soluble FITC (MESF). The mean fluorescence of the labelled bacteria was 1300 
MESF (range 600 - 2900), implicating approximately 650 molecules of polyclonal FITC-
F(ab’)2 anti-IgA per bacterium (F/P ratio = 2) and therefore less than 650 molecules of IgA.  
Since match region subtraction is an artificial method that harbours the danger of over- as well 
as of underestimation of the real of percentage coated bacteria, we also performed conventional 
simple threshold analysis with the threshold set at a FITC-fluorescence level at which only 0.2 
% of the nonstained bacteria were positive (2100 MESF). By this method 13.4 % (4 - 30 %) of 



















Figure 2. Flow cytometry analysis of fecal samples from 22 healthy human volunteers. Fecal anaerobic 
bacteria, isolated by centrifugation, were washed, stained with FITC - F(ab’)2 anti-Hu IgA, IgG or IgM 
and 10,000 events per staining were analysed. The percentages of fecal bacteria coated with IgA, IgG or 
IgM present in each fecal sample are shown as determined by match region subtraction (fig 2a, left 
figure) and by conventional threshold analysis (fig 2b, right figure). The threshold was set at a FITC 
fluorescence larger than 2100 MESF, i.e. larger than all nonstained bacteria. The median percentage is 
visualized with a line.  
 
 
The fluorescence distribution in most samples was characterized by a majority of bacteria with 
low and intermediate specific fluorescence intensities and only a tail of strongly fluorescent 
bacteria (fig 1). The mean fluorescence intensity of the most strongly labelled bacteria (top 1 % 
of all bacteria) present in each sample was 2.5 x 105 MESF. Although the size of bacteria could 
determine their IgA coating intensity, there was no clear correlation between bacterial size 
(forward scatter (FSC), 11) and their labelling with FITC anti-IgA (fig 3a). In fact, the majority 
of the strongly IgA coated bacteria had low FSC. In about half of the samples these bacteria 
formed a small (< 3 %) distinct population in a FSC - fluorescence plot (fig 4). 
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Figure 3. Typical relation between size (forward scatter, FSC) and FITC-fluorescence (MESF) of 
bacteria present in a fecal sample stained with FITC anti-Hu IgA, IgG or IgM (resp. 3a, 3b, 3c) as 
determined by flow cytometry. Nonstained bacteria are shown in fig 3d. For each staining 10,000 









Figure 4. In few of the fecal samples a distinct 
population of strongly IgA coated bacteria was 
found in the FSC (bacterial size) versus FITC-
fluorescence scatterplot. Here we show the FSC - 
FITC-fluorescence scatterplot of one of these 
samples stained with FITC anti-Hu IgA. 
Fluorescence values are expressed in MESF. 
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In vivo coating with IgG or IgM 
The in vivo coating of fecal anaerobic bacteria with IgG and IgM was also determined by flow 
cytometry. Fig 2a shows that the median percentage of bacteria labelled with FITC anti-IgG as 
analysed with match region subtraction was 25 % (range 12 - 39 %). The labelled bacteria had 
a mean specific fluorescence of 700 MESF (range 500 - 1100 MESF). With threshold analysis, 
3.5 % (range 1.5 - 8.1 %) of the bacteria were labelled (fig 2b). The fluorescence distribution of 
most samples was characterized by relatively low specific fluorescence intensities in the great 
majority of bacteria while strongly fluorescent bacteria were absent. There was no relation 
between bacterial size (FSC) and labelling with FITC anti-IgG (fig 3b). In FSC - fluorescence 
plots, no distinct populations of strongly IgG coated bacteria were seen. 
The median percentage of bacteria labelled with FITC anti-IgM was 11 % (fig 2a, range 5 - 41 
%). Despite this lower percentage compared to IgG, the mean fluorescence intensities of IgM 
coated bacteria were higher: 1100 MESF (range 600 - 2200 MESF). This was due to a much 
smaller population with low fluorescence intensities and a ‘tail’ of bacteria with higher 
fluorescence intensities. With threshold analysis, only 2.6 % (range 0.4 - 9.1 %) of the bacteria 
were labelled (fig 2b). There was no relation between bacterial size (FSC) and labelling with 
FITC anti-IgM (fig 3c). In the FSC - fluorescence plot of only one sample, a distinct population 
of strongly IgM coated bacteria was seen. This population had similar FSC compared to the 
population of strongly IgA coated bacteria present in the same fecal sample. 
 
IgA coated bacteria in small fecal mucus flocks (mucus flora) 
The composition of the mucus flora as well as the concentration of immunoglobulins within the 
mucus layer may be different from that of the lumen flora and lumen. Furthermore, the major 
interaction of bacteria with the mucosal immune system occurs within the mucus layer (mucus 
flora) covering the colon epithelium. By analysis of single fecal bacteria, however, only the 
lumen flora is investigated and this may introduce a bias. Therefore, small irregular flocks 
present in all fecal suspensions (and containing mucus flora) were analysed by phase contrast 
microscopy. The flocks were found to consist of densely packed bacteria embedded in an 
amorphous substance (fig 5). Most flocks had a diameter of about 15 µm, although some 
exceeded 300 µm. Routine microscopic counting revealed that the flocks were present in a 
concentration of about 107 flocks / gram of feces. All flocks stained with alcian blue indicating 
that indeed they contain intestinal mucus.  
We wondered whether the bacterial population present within mucus flocks (mucus flora) is 
comparable to the population present as separate bacteria (and small agglutinates) scattered 
around the flocks (lumen flora). Therefore, we analysed both populations by phase contrast 
microscopy (fig 5). The flocks contained a very heterogeneous bacterial population that 
morphologically very much resembled the population present as separate bacteria. Furthermore, 
visual evaluation by fluorescence microscopy of samples stained with polyclonal FITC F(ab’)2 
anti-Hu-IgA was performed. Since the eye, opposed to flow cytometry, is not very sensitive for 
light, only strongly fluorescent bacteria could be detected. Flocks in all 22 samples contained 
bacteria with perceptible fluorescence, however, the great majority of bacteria had no visible 
fluorescence. The most strongly fluorescent bacteria within flocks had comparable morphology 
to those present as strongly fluorescent separate bacteria in the corresponding suspensions (fig 
5). This suggests that the bacterial population present in mucus flocks (mucus flora) is similar 
to the bacterial population present as separate bacteria in fecal suspensions (lumen flora). 
Since dimeric sIgA may agglutinate bacteria, we have carefully analysed both flocks and lumen 
flora (separate bacteria and small agglutinates), for the presence of two or more strongly 
fluorescent bacteria agglutinated with each other (lying side by side). However, agglutination 
of strongly fluorescent bacteria was not seen (fig 5). 
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Figure 5. Phasecontrast microscopic view of a fecal suspension shows a representative mucus flock that 
it is densely packed with bacteria (2400 x). Several separate bacteria are seen in the surroundings (left 
picture). The corresponding immunofluorescence picture after staining for IgA shows few scattered 







Here we show that approximately half of the (anaerobic) bacteria present in fecal suspensions 
of healthy human volunteers are coated with IgA (24-74%), while much less bacteria are coated 
with IgG or IgM and others are not coated at all. Yet, the colonic mucosa is only mildly 
inflamed. 
 
Absence of IgA coating of a large  portion of the anaerobic colonic flora 
Our findings clearly demonstrate that not all bacteria are in vivo coated with IgA despite of an 
enormous amount of IgA present in the lumen. Fecal dry weight consists of 75 % bacteria of 
which over 99.9 % are anaerobic. Thus, the fecal flora comprises an enormous amount and 
variety of antigens 1 - 3, 14. Anaerobic bacteria form a relatively stable ecosystem in a characteristic 
composition for each human individual, comprising presumably as many as 400 different 
predominantly nonpathogenic indigenous species 1 - 3. There is a continuous nonspecific uptake 
of particulate (i.e. bacteria) and soluble antigens from the gut lumen by specialised epithelial 
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cells (i.e. M cells), normal epithelial cells and via tight junctions 4, 15. It is therefore plausible, 
that antigens of all colonizing anaerobic species are continuously present within the mucosa 
and presented to the mucosal immune system. The major effector system of the specific 
mucosal immune system is secretory IgA (sIgA). Large amounts of sIgA (2.5 g / day), almost 
entirely produced by the mucosal immune system, are secreted into the lumen of the digestive 
tract 16. Rough estimates indicate that there are about 107 sIgA molecules (specific as well as 
nonspecific) available per fecal bacterium. Nevertheless, despite this enormous amount of IgA, 
in vivo many bacteria are apparently not measurably coated with IgA.  
Theoretically, the absence of IgA coating on many bacteria may be due to faecal proteases 
within the intestinal fluid that may cleave Ig molecules into a Fc portion and a F(ab’)2 
fragment. However, feces contains only very little proteolytic activity 17. Furthermore, our 
polyclonal FITC - anti-Hu IgA contains specificity for the F(ab’)2 portion of IgA and therefore 
FITC - labelling would not be influenced by this proteolytic activity. Indeed, a considerable 
number of bacteria was coated with IgA. Thus, fecal proteolytic cleavage of sIgA present on 
fecal bacteria also cannot explain the absence of IgA on many of these bacteria.  
A second potential bias is the possible difference between the mucus flora and the flora 
analysed (fecal flora). However, in this study we could not detect major differences in 
composition and as well as IgA coating between both bacterial populations. 
Although even a few hundred Ig molecules can be detected with the flow cytometry method, 
the presence of smaller numbers of Ig molecules on bacteria cannot be excluded 11, 12. 
Furthermore, IgA with low-avidity may have been washed off during the staining procedure. 
For all these reasons, a true complete humoral non-responsiveness is not proven but yet likely. 
Two immunological mechanisms may explain absence of IgA coating (mucosal immunological 
nonresponsiveness) of fecal bacteria. First, bacteria may use camouflage techniques by 
expression of host-identical epitopes on their surface antigens (intrinsic immunological 
nonresponsiveness). It is plausible that intestinal bacteria, during long periods of colonization, 
either can adapt to their host’s immune system or are selected for non-immunogenicity 18. 
However, only relatively few intestinal bacteria expressing antigens cross-reacting with host 
antigens are known and it is improbable that all their surface antigens resemble host-antigens.19 - 
21
. In addition, there is no direct evidence yet that expression of cross-reacting antigens helps 
bacteria to evade the immune system. 
A second mechanism which could explain a lack of IgA coating of anaerobic bacteria is 
acquired mucosal immunological nonresponsiveness, resulting in suppression of the specific 
mucosal immune response 8. This may be induced by the continuous presence of large amounts 
of antigens in the digestive tract. There is evidence that diminishment or even absence of a 
specific mucosal IgA response may occur after prolonged feeding of bacterial antigens 6, 7, 22 or 
nonbacterial proteins 5. Acquired mucosal immunological nonresponsiveness for anaerobic 
bacterial antigens may be effective in the prevention of mucosal inflammation. However, it 
harbours the danger of derailment with consequent loss of immunological nonresponsiveness 
and thus a risk for mucosal inflammation. Such derailment could play a role in the pathogenesis 
of idiopathic inflammatory bowel disease. 
 
Many fecal anaerobic bacteria are coated with IgA 
Despite the fact that presumably as many as 45 % (match region subtraction), and at least 13 % 
(conventional threshold analysis), of the bacteria are coated with IgA, the colonic anaerobic 
flora comprises a relatively stable ecosystem of a heterogeneous bacterial population 
colonizing the mucus. This is surprising because several antibacterial functions are attributed to 
IgA. For example synergism of IgA with nonspecific antibacterial factors (i.e. lactoferrin), 
immune exclusion (bacterial agglutination, prevention of epithelial attachment and prevention 
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of epithelial invasion) and inactivation of bacterial enzymes 9, 23 should put IgA coated bacteria 
in a disadvantaged position. However, our findings make likely that IgA-coating of these 
colonic anaerobic bacteria does not substantially hinder their mucosal adherence and mucus 
colonisation.  
In about half of the samples strongly IgA coated bacteria were found as a separate population in 
the FSC - fluorescence plot. This strong IgA coating may represent either a primary immune 
response to a recently arrived species, or an enhanced secondary immune response against a 
more invasive species. 
‘Nonspecific’ staining of bacteria might be caused by nonspecific binding of the polyclonal 
FITC - F(ab’)2 anti-Hu IgA as well as by nonspecific binding of the luminal secreted 
immunoglobulins. Nonspecific binding of polyclonal FITC goat - F(ab’)2 anti-Hu IgA with 
coated immunoglobulins or with bacterial surface antigens has been previously studied and 
does not occur 11. Nonspecific binding of the lumenal secreted immunoglobulins to bacteria 
may be present since several aerobic bacterial species contain B cell superantigens. B cell 
superantigens, e.g. staphylococcal Protein A, are bacterial antigens that nonspecifically bind to 
a large proportion of IgA, IgG or IgM 24. However, it is not known whether anaerobic species 
carry B cell superantigens. Furthermore, nonspecific binding of immunoglobulins may have the 
same effects on bacteria as specific binding. 
Agglutination of bacteria is believed to be an important mechanism by which dimeric sIgA 
prevents bacteria entering the mucosa 9. However, in this study agglutination of strongly IgA 
coated (anaerobic) bacteria was neither seen in mucus flocks, where IgA concentrations may be 
high and influence of peristalsis is low, nor in fecal suspensions. This suggests that the resident 
anaerobic bacteria must have developed yet unknown strategies to evade agglutination. 
In conclusion, sIgA may play a different role for indigenous anaerobes than for transient 
organisms that may be pathogens. IgA coating may stabilize the colonic flora and attribute to 
the colonization resistance 25. 
 
In vivo coating with IgG and IgM 
In the present study we show that on average 25 % of all bacteria present in fecal suspensions 
are coated with IgG, whereas about 11% are coated with IgM. The presence of IgG and IgM 
coated bacteria is plausible since the colon harbours 1010 plasma cells per meter of which 4 % 
secrete IgG and 6 % IgM, besides the predominant IgA secreting plasma cells (90 %) 26.  
In contrast to intestinal IgA and IgM, which are almost exclusively produced within the 
mucosa, intestinal IgG is presumably derived from serum as well 26. The function of mucosal 
(intestinal) IgG is not known, although blocking of bacterial adherence to epithelial cells has 
been described 27. Since IgG is a monomer and, in contrast to secretory IgA, susceptible to 
proteolytic activity, it may be less effective in opsonisation and agglutination of bacteria in the 
intestinal lumen 28. Therefore, its function may lay merely within the mucosal tissue. The 
coating of anaerobic bacteria with IgG in the intestinal lumen may have no influence of their 
colonisation and may be partly the result of a leakage of IgG into the lumen.  
IgM usually is polyreactive with specificity for carbohydrate antigens, which are often 
expressed on bacterial surfaces. Therefore, sIgM may be important in the first line of defense 
against invading bacteria. However, despite the polyreactive nature of IgM, only a small 
percentage of fecal anaerobic bacteria was coated with IgM. This suggests either that these 
polyreactive IgM molecules have low avidity and have been washed off during the staining 
procedure, or absence of mucosal polyreactive IgM with specificity for the anaerobic bacteria. 





We conclude that a relatively large proportion of anaerobic fecal bacteria are not in vivo coated 
with IgA and a somewhat smaller proportion are not coated with Ig at all. This may be largely 
due to acquired mucosal immunological nonresponsiveness. Still a substantial proportion of 
anaerobic fecal bacteria are coated with IgA and less with IgG or IgM. Since the colonic flora 
have nevertheless a stable composition and the colonic mucosa is normally only mildly 
inflamed, this Ig-coating cannot be harmful, neither to these bacteria nor to their host. It is 
important to realise that most anaerobic bacteria are beneficial to the host 29 and therefore, 
killing or rejection of commensal bacteria may not be the goal of the mucosal immune system 9. 
Both immunological nonresponsiveness for certain colonizing bacteria and coating with IgA of 
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Background. An inappropriate mucosal immune response to the commensal bacterial flora may 
play a role in the pathogenesis of IBD. Here we determined the percentage of immunoglobulin 
coated bacteria in the stools of patients and controls. 
 
Methods. Fecal samples were obtained from: 18 patients with IBD (one sample during 
exacerbation and one shortly after remission was achieved), 15 healthy volunteers, 8 infectious 
colitis patients and 13 IBD patients in long term remission. Bacterial immunoglobulin coating 
was determined by flow cytometry analysis. Fecal alpha-1-antitrypsin concentrations were 
determined by radial immune diffusion. 
 
Results. IBD patients had 69±19% IgA, 56±32% IgG and 56±29% IgM coated bacteria in their 
feces. Healthy controls had less immunoglobulin coating: respectively 36±12%, 11±4% and 
11±7% (all: p < 0.00001). Infectious colitis patients had IgA: 57±14%, IgG: 31±13% (p<0.05, 
IBD) and IgM: 42±16%; however, they had higher fecal alpha-1-antitrypsin concentrations 
than IBD patients. Shortly after remission IBD patients had: IgA: 65±20%, IgG: 32±18%, IgM: 
40±21%. Long term remission IBD patients had normal IgG and IgM, though increased IgA 
(50±16%) coating. 
 
Conclusions. Compared to healthy controls, patients with IBD had an increased percentage of 
Ig coated fecal anaerobic bacteria, both in active disease, and shortly after remission. These 
results support the concept that there may be a breakdown of mucosal tolerance to the 






The etiology and pathogenesis of ulcerative colitis and Crohn’s disease (Inflammatory Bowel 
Diseases, IBD) are not known. However, circumstantial evidence suggests that the commensal 
intestinal bacterial flora may play a crucial role in the disease process 1,2. This conclusion is 
based on the following arguments: (i) IBD occurs most frequently in intestinal regions 
colonised by the highest bacterial concentrations (colon and terminal ileum); (ii) Crohn’s 
disease (but not ulcerative colitis) may improve when luminal bacterial concentrations are 
reduced by elemental diets 3, split ileostomy 4, 5, intestinal lavage 6 or broad spectrum antibiotics 
7, 8; (iii) rechallenge of an excluded colon or neoterminal ileum with autologous intestinal 
contents results in mucosal inflammation 4, 9; (iv) mice with a targeted deletion for T cell 
receptor alpha, IL-2 or IL-10 and rats transgenic for HLA-B27 develop colitis when they are 
maintained under conventional conditions but not under germfree conditions 10-13. Collectively, 
these data suggest that the presence of indigenous bacteria is required for the induction of 
intestinal inflammation in IBD. How the intestinal microflora is involved in the pathogenesis 
remains, however, unclear. At present there are no convincing data supporting a crucial role for 
a particular bacterial strain in the pathogenesis of IBD. A decreased intestinal mucosal barrier 
function may lead to an influx of commensal bacteria and their antigens into the mucosa with 
subsequent development of inflammation. Findings by Duchmann et al. suggest that there 
exists some sort of mucosal tolerance for individuals own microflora, which is disrupted in 
patients with IBD. Their data show that mucosal T cells, isolated from the colon of healthy 
individuals, do not proliferate in response to commensal colonic bacteria derived from the 
same individual whereas these T cells proliferate in the presence of bacteria derived from 
another individual 14. In marked contrast, however, mucosal T cells from IBD patients with 
active disease proliferate intensely when incubated with commensal bacteria derived from the 
same patient. The authors speculate that the abrogated (oral) tolerance noted in IBD patients 
may lead to immune responses at these mucosal sites, resulting in inflammation and finally in 
IBD. In line with these observations we have shown recently, applying a newly developed 
flow-cytometrical method, that in healthy individuals only a fraction of the fecal bacteria are 
coated with IgA, IgG or IgM 15. This observation suggests that tolerance for the indigenous 
microflora is not only reflected by reduced cellular responses against bacteria in the gut lumen 
but also at the level of the humoral response, witnessed by the absence of coating of antibodies 
to a large proportion of fecal bacteria. In the present study we have tested this hypothesis 
further by determining the percentage of fecal bacteria coated with IgG, IgM and IgA in the 





Materials and methods 
 
Patients 
Crohn’s disease: Fecal samples from patients with Crohn’s disease (CD) (6 males and 7 
females, mean (SD) age 37.2 (13.8) years) were obtained, one sample during exacerbation and 
one during remission (in three patients only a single sample during exacerbation was obtained 
and in one patient only a sample in remission). The patients received an elemental diet 3 but no 
immunosuppressive drugs or 5-aminosalicylic acid. Disease activity was defined by the Harvey 
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& Bradshaw Index (HBI) 16, colonoscopy and serum levels of C-Reactive Protein and alpha-1-
anti chymotrypsin. Patients with CD were considered to be in remission when the HBI was less 
than 3.  
Ulcerative colitis: Fecal samples were also obtained from patients with ulcerative colitis (UC) 
(4 males and 1 female, mean (SD) age 46.6 (9.1) years), one during exacerbation and one 
during remission. One UC patient donated only a sample during remission and the percentage 
of IgA coated bacteria could not be determined in one sample. In contrast to CD patients, all 
UC patients were treated with 5-aminosalicylic acid preparations together with either systemic 
or local steroids. Disease activity was based on a clinical symptom score and sigmoidoscopy. 
Patients with UC were considered to be in remission when healing of the mucosa was observed 
at sigmoidoscopy.  
Long term remission: Stool samples were collected from 13 other IBD patients (10 UC patients 
and 3 with Crohn’s disease: 6 males and 7 females, mean (SD) age 46 (17) years) with long 
term quiescent disease (at least two years in clinical remission and with normal erythrocyte 
sedimentation rate (ESR) and C-reactive protein). 
Healthy controls: As controls, stools were obtained from 8 healthy volunteers and 7 patients 
attending our out-patient clinic because of Irritable Bowel Syndrome (8 males and 7 females, 
mean (SD) age 32.5 (8.1) years). Since both control groups had similar percentages of Ig 
coated bacteria, they together were regarded as healthy controls in this study (n=15).  
Acute infectious colitis: Stool samples were also obtained from 20 non-IBD patients presenting 
with acute bloody diarrhoea (samples were obtained within 10 days of onset of the diarrhoea). 
Eight patients (1 male and 7 females, mean (SD) age 39.6 (24.7) years) had positive fecal 
cultures (5 with Campylobacter spp. and 3 with Salmonella spp.) and a macroscopic colitis on 
sigmoidoscopy and were thus diagnosed as acute infectious colitis.  
Patients and controls had not used antibiotics within two weeks of sampling. All fecal samples 
were divided into portions of 0.5 gram, frozen within five hours after voiding and stored until 
use at -20°C. 
 
Laboratory analysis 
Reagents: Affinity-purified polyclonal fluorescein isothiocyanate (FITC)-labeled goat F(ab’)2 
anti-human IgA, IgG, IgM (F/P ratios 2.0, Kallestad, Austin, TX), Bovine serum albumin 
(BSA, fraction V, Boehringer Mannheim, Mannheim, Germany), and propidium iodide 
(Sigma, St Louis, MO). 
Flow cytometry: Half a gram of feces was suspended in 4.5 ml filtered (Millipore 0.22 µm ) 
PBS, homogenized on a Vortex mixer and centrifuged at low speed to separate larger fecal 
particles from bacteria. Twenty µl of the supernatant (containing approximately 108 bacteria) 
was washed and centrifuged at 8000g for 10 min. The pellet was resuspended in 60 µl BSA / 
PBS (1% (w/v)) containing 1% (v/v) FITC-labeled F(ab)2 anti-Hu IgA, IgG or IgM. As a 
control a pellet was resuspended in 60 µl BSA / PBS (1% (w/v)). After a 30 min incubation 
period, suspensions were washed twice with PBS. Finally, the bacterial pellet was resuspended 
(Vortex) in 500 µl PBS, mixed with 20 µl PI (100 mg / l), stored on ice in the dark and 
analysed within two hours. Flow cytometry analysis was performed with an EPICS - ELITE 
(Coulter - Electronics, Hialeah, Fl) equipped with an Argon laser operating at 15 mW and 488 
nm  as described previously 17. Calibrations were done with Fluoresbrite plain microspheres 
(Polysciences, Inc., Warrington, PA) 0.72 µm in diameter, on forward scatter (FSC) and side 
scatter. Measurements were performed on 20,000 events, at a flow rate of 1000 - 2000 events / 
sec. The FITC - fluorescence was recorded logarithmically. All particles that stained with 
propidium iodide (PI) were regarded as bacteria and therefore, the discriminator was set on PI - 
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fluorescence. An additional gate was set to exclude events with very large FSC (particles larger 
than single bacteria). Analysis was done with standard ELITE software comprising the 
Immuno-4 program to determine the percentage of stained events by match region subtraction 
17
. The matched region ranged 10 - 80 units (of a total region of 1024) for all samples. 
Fecal alpha-1-anti trypsin (α1-AT) concentration: In most samples, the fecal α1-AT 
concentration was determined by radial immunediffusion with commercially available partigen 
plates (LC-partigen, Behring AG, FRG). An aliquot of lyophilised stool (250 mg) was 
extracted according to the method of Crossley and Elliott with 5 ml of distilled water by gently 
mixing over 30 minutes at 22° C 18. After centrifugation (12000 g for 30 minutes at 4° C) 5 µl 
of the supernatant were placed into the wells of partigen plates. The diameter of the 
precipitating rings was measured after 72 hours. Fecal α1-AT concentration was expressed in 
mg α1-AT/g dry stool weight. The upper limit of the normal values is 2.6 mg / gram dry feces. 
 
Statistics 
Differences in the percentage of bacterial Ig coating were evaluated with the unpaired t-test. 
Differences between samples of the same patient at different time points were evaluated with 
























Figure 1. Percentages of fecal bacteria coated with IgA, IgG, and IgM from: patients with infectous 




Ig coating of fecal bacteria in IBD patients and controls  
The percentage of bacteria coated with Ig was determined by flow cytometry analysis and 
subsequent match region subtraction. The fecal flora of IBD patients with active disease 
contained 69±19% IgA coated bacteria, 56±32% IgG coated bacteria and 56±29% IgM coated 
bacteria. These percentages are significantly higher than found in healthy controls which were 
36±12%, 11±4% and 11±7% respectively (all: p < 0.001). There was no difference in the 
number of Ig coated bacteria between Crohn’s disease and ulcerative colitis (figure 1).  
Analysis of feces of patients with infectious colitis also revealed an elevation of Ig coating 
(figure 1): 57±14% was coated with IgA, 31±13% with IgG and 42±16% with IgM. These 
percentages are significantly higher than found in healthy controls (IgA: p<0.005, IgG and 
IgM: p<0.001) but lower than in patients with active IBD (IgG: p<0.05). 
 
Disease activity 
For most patients two fecal samples were analysed: one at presentation with active colitis and 
one shortly after remission. Clinical remission was associated with a decrease in Ig coating: 
IgG from 56±32% to 32±18% (p < 0.01) and IgM from 56±29% to 40±21% (p < 0.05). 
However, the percentage of IgA coating remained unaltered (65±20%, figure 2). Despite this 
decrease in Ig coating, the percentages were still higher than in healthy controls (IgG, IgM: 
p<0.001). Patients with long term quiescent disease (at least two years in clinical remission and 
with normal erythrocyte sedimentation rate (ESR) and C-reactive protein) had normal 
percentages of IgG and IgM coating (respectively 13±4% and 16±9%), though an elevated 






















Figure 2. Percentages of fecal bacteria coated with IgA, IgG, and IgM. Paired fecal samples were 
collected from patients with active colitis (black symbols) and recent remission (open symbols) with 






















Figure 3. Percentages of fecal bacteria coated with IgA, IgG, and IgM from IBD patients who are in 
clinical remission for more than 2 years. (○ Crohn’s disease, ∆ Ulcerative Colitis). 
 
 
Fecal alpha 1 anti trypsin concentration 
To obtain an estimate of the serum leakage through the mucosa into the intestinal lumen the 
concentration of fecal α1 anti trypsin (α1-AT) was determined. Only 2 out of 10 fecal samples 
from patients with active IBD showed elevated α1-AT concentrations (median of all 10 
samples: 0.7 mg α1-AT /gr dry feces). In contrast, 5 out of 7 fecal samples from patients with 
acute infectious colitis had increased α1-AT concentrations (median concentration: 4.4 mg α1-
AT /gr dry feces) (p<0.005) whereas this occurred in none of the 13 healthy control samples 







IBD patients with active disease have an increased percentage of IgA, IgG and IgM coated 
fecal anaerobic bacteria compared to healthy controls. Clinical and experimental evidence 
indicates that the normal gut flora is involved in the pathogenesis of IBD 1, 2, 4, 5, 7-13. Our findings 
support this concept. How can this increase in Ig coating of fecal bacteria in patients with IBD 
be explained ? Little is known about the interaction of intestinal bacteria and the antibodies 
produced in the intestinal mucosa. The normal indigenous flora is a major stimulus for mucosal 
IgA production, as evidenced by the absence of Ig secreting plasma cells in the gut lamina 
propria of germfree and antigen free mice 19. Studies with monoassociated germfree mice show 
that autochtonous bacteria such as segmented filamentous bacteria do indeed induce mucosal 
IgA production, although only a minor fraction (1-2%) of this IgA appears to be specific 20. 
Despite the ability of at least some commensal bacteria to induce (polyclonal) IgA responses, 
these bacteria persist in the gut lumen. Furthermore, we have shown that in healthy humans 
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only 24-74% of the fecal anaerobic bacteria are coated with IgA, and much less with IgM and 
IgG 15. Likewise in mice only a small percentage of fecal bacteria are coated with IgA 21. The 
low level of immunoglobulin coating of fecal indigenous bacteria in healthy humans may well 
be explained by the existence of some kind of tolerance (or unresponsiveness) of the (mucosal) 
immune system for indigenous fecal bacteria 1, 14, 15. Our findings that in patients with IBD higher 
percentages of fecal bacteria are coated with IgA, IgM and IgG support the concept that in this 
disease there is breakdown of mucosal tolerance to the intestinal flora 1, 2, 14. Mucosal T cells 
from IBD patients with active disease proliferate intensely when incubated with commensal 
bacteria derived from the same patient, whereas mucosal T cells from healthy controls do not 
respond 14. With regard to the humoral immune response, we show here that this postulated 
breakdown of tolerance also may result in increased coating of the cell surface of intestinal 
bacteria. Breakdown of tolerance may thus lead to a cellular and humoral immune response to 
the bacterial flora finally resulting in inflammation.  
How tolerance at mucosal sites is regulated is still not exactly known, but it is clear that many 
different cells, cytokines and other factors are involved. Any perturbation in this complex 
system may lead to an immune response to enteric bacteria of the indigenous flora. For 
example, mice deficient in either IL-2 or IL-10 production both develop colitis when they are 
maintained under conventional conditions but not under germfree conditions 10-13. Current 
theories suggest a role for the so called mucosal regulatory Tr1 cells in maintaining tolerance. 
Tr1 cells are antigen specific mucosal CD4+ T cells that produce large amounts of Il-10 in 
response to antigen recognition. Il-10 may suppress activation of other T cells in the local 
environment hereby inducing a more general mucosal tolerance including the humoral immune 
response 22. 
Although breakdown of tolerance might well explain the increased Ig coating of fecal bacteria 
in IBD patients, other explanations should also be considered. Firstly, serum Ig may potentially 
contribute to the Ig coating of bacteria. Apperloo et al., have shown that the serum of healthy 
individuals contains Ig that can bind to fecal anaerobic bacteria 23, 24. Thus, in theory, leakage of 
serum into the bowel at sites of inflammation might result in a higher percentage of Ig coated 
bacteria in IBD patients. However, in active IBD the contribution of serum Ig to the luminal Ig 
in the colon is relatively small 25. Indeed, we have shown here that only 2 out of 10 fecal 
samples of IBD patients with active disease had elevated fecal α1-AT concentrations (a 
measure of transmucosal serum protein leakage 26). For this reason, we consider it unlikely that 
serum derived Ig contributes significantly to the Ig coating of fecal bacteria in IBD patients. By 
contrast, in infectious colitis the relative contribution of serum Ig to the bacterial Ig coating 
may be considerably higher as these patients were specifically chosen because of having 
bloody diarrhoea, and showed an increased leakage of α1-AT. Furthermore, in infectious 
colitis the mucosal IgG and IgM production may be normal. In contrast to IBD in which there 
is a tenfold increase in the number of IgM and IgG producing plasma cells within the diseased 
mucosa, in infectious colitis normal numbers of mucosal IgG and IgM plasma cells are found 
27,28
. Thus, the observed coating of bacteria seen in infectious colitis might well be due to serum 
leakage rather than increased mucosal production. 
A second explanation for the increased Ig coating of fecal bacteria might be that there is a 
selective expansion or overgrowth of bacterial species to which the Ig is directed. Although the 
microflora is known to play a crucial role of in the pathogenesis of IBD, despite repeated 
investigations, there is at present no evidence that in IBD only one or a few specific bacterial 
species are involved in the pathogenesis. Such analysis might be hampered by the fact that 
anaerobic bacteria are difficult to culture and identify. Currently we address this issue with 
bacteria-specific 16S RNA probes to analyse the composition of the gut flora in IBD 29. 
When IBD patients achieve remission the Ig coating of the fecal bacteria decreases, although 
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levels of IgA, IgG and IgM coating are still elevated compared to healthy controls. However, 
when patients are in long term remission, the percentages of Ig coated bacteria return to control 
values. Thus, initial, clinical remission of IBD patients occurs before coating of bacteria 
returns to normal. It might be that these patients are at a stage of subclinical active IBD. 
Reimund et al. have demonstrated that in histologically normal intestinal biopsies from 
Crohn’s disease patients levels of Il-6, TNFα  and Il-1b are elevated and Louis et al. observed 
that high serum Il-6 concentrations were sometimes present in patients with quiescent Crohn’s 
disease 30, 31. Furthermore, in subclinical active disease microgranulomas may still be detectable 
in the rectal mucosa 32. This suggests that the apparent dysregulation of the mucosal immune 
system may persist for some time despite healing of the mucosa. Patients with subclinical 
active IBD may be at greater risk of an exacerbation 33.  
Our data do not provide a decisive answer to the question as to whether the proposed 
breakdown of mucosal tolerance is a primary or secondary event in the pathogenesis of IBD. 
The observation that IBD patients in long term remission have normal percentages of Ig coated 
bacteria may favor the hypothesis that the proposed breakdown of mucosal tolerance is a 
secondary phenomenon. It may be a consequence of exposure of the mucosal immune system 
to the intestinal flora as a result of damage to the colonic epithelial lining. However, it could 
also be a primary event in the pathogenesis of IBD. It may wax and wane in a similar fashion 
to changes in the activity of  systemic auto-immune diseases such as Wegener’s 
granulomatosis, rheumatoid arthritis and systemic lupus erythematosus (SLE). However, 
irrespective of cause, loss of mucosal immune tolerance for the luminal bacterial flora will 
contribute to mucosal inflammation. 
In conclusion, IBD patients with active disease have an increased percentage of IgA, IgG and 
IgM coated fecal anaerobic bacteria in comparison to healthy controls. These data support the 
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Background. The intestinal microflora plays a role in inflammatory bowel disease. In these 
patients there is an increase of faecal bacteria coated with immunoglobulins. However, it is not 
known which bacteria are coated. To investigate this, we developed a flow cytometric method 
that combines fluorescent in situ hybridisation (FISH) and immunofluorescence.  
 
Methods. Faecal suspensions were subjected to FISH with CY5 labeled 16S rRNA targeted 
oligonucleotide probes with specificity for four of the major faecal bacterial populations 
followed by staining with Rhodamine-Phycoerythrin labeled anti-Hu IgA and analysed by flow 
cytometry. SYBR Green I staining small particles were regarded as bacteria. Percentages 
hybridisation and staining were determined with ‘matched region subtraction’, a histogram 
subtraction method. Microscopic counting coupled to image analysis was used as a control.  
 
Results. With flow cytometry, bacteria of the Clostridium coccoides and Eubacterium rectale 
group could be identified in all samples and with higher sensitivity (52±19% vs 19±7%, 
p<0.005) than image analysis. Image analysis, however, was more sensitive for smaller 
populations: with flow cytometry bifidobacteria could be identified in 9, eubacteria low G+C 
#2 group in 8, and Atopobium group in 3 samples, whereas with image analysis these bacteria 
were identified in nearly all samples. At the expense of loss of sensitivity it was possible to 
combine FISH with immunofluorescence. Herewith, we found an increased IgA-coating of 
bifidobacteria (30±20% vs 13±5% (p<0.05)).  
 
Conclusions. We describe a new flow cytometric method to analyse bacterial populations 
within faeces with FISH and immunofluorescence. We show that bifidobacteria have an 
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Introduction 
 
The human colon harbors a complex microbial ecosystem consisting of as many as 400 
different species, usually referred to as the normal commensal microflora. This microflora 
mainly (>99.9 %) consists of obligatory anaerobic bacteria. Each individual has a 
characteristic commensal microflora in the colon that is relatively stable over time 1. Despite 
this large amount of bacteria, the normal human colon is not inflamed. An intact barrier, 
consisting of the mucus layer and the epithelial lining, in combination with mucosal 
immunological tolerance for the commensal colon flora, are presumably responsible for the 
absence of colonic inflammation.  
The intestinal microflora plays a role in the pathogenesis of inflammatory bowel disease, 
especially in Crohn's disease. Modulation of the microflora with antibiotics, probiotics or diet 
may induce a remission in inflammatory bowel disease. Furthermore, there are many animal 
models that spontaneously develop colitis, unless they are kept germ free. Collectively, these 
data suggest that the presence of indigenous bacteria is required for the induction of intestinal 
inflammation in IBD 2, 3. How the intestinal microflora is involved in the pathogenesis remains 
unclear. At present there are no convincing data supporting a role for a particular bacterial 
strain in the pathogenesis of IBD. Recently, we have shown that in patients with active IBD 
there is an increase of faecal bacteria coated with IgA, IgG and IgM 4. This increase may either 
be caused by a general increase of immunoglobulin coating of all bacterial species or by an 
increased coating of certain bacterial groups. In the present study we describe a new flow 
cytometric method to determine within faecal suspensions the bacterial groups that are coated 
with immunoglobulins. 
Fluorescent in situ hybridisation (FISH) with fluorescent 16S rRNA-targeted oligonucleotide 
probes is well validated as a culture-independent method to investigate the composition of the 
faecal bacterial flora 5. The specificity of rRNA-targeted probes can be chosen in a way that 
they hybridise with nearly all bacteria (probe EUB338) or specific groups of bacteria (e.g. 
probe BIF164 which specifically hybridises with bifidobacteria). With FISH fluorescent 
bacteria can be quantified within faecal suspensions by microscopic visual counting, 
automated microscopic counting with image analysis 5, and flow cytometry 6. Flow cytometric 
analysis of bacteria with rRNA-targeted probes (FISH) has been described by several authors 
in artificial mixtures 7, activated sludge 8 and soil 9. Recently, a study has been published on the 
flow cytometric quantification of Ruminococcus obeum-like bacteria within faeces with FISH 
10
. To distinguish bacteria from background noise, these studies set the threshold at forward 
scatter (a measure of bacterial size) or side scatter. However, within faecal suspensions many 
bacteria are so small that they are within the forward scatter and side scatter background noise 
11
. Therefore, in the present study we used SYBR Green I 12 as an extra fluorochrome to stain all 
bacteria and the threshold was set on SYBR Green I fluorescence.  
Wallner et al 13 performed flow cytometric analysis of triple stained artificial bacterial mixtures 
with a fluorescein-labeled rRNA-targeted probe, a biotinylated bacteria specific antibody that 
could be detected by phycoerythrin (PE)-conjugated streptavidin, and the DNA-specific dye 
DAPI to stain all bacteria. They set the threshold at DAPI fluorescence. A second study 
describes the combination of TRITC-labeled rRNA-targeted probes, fluorescein-labeled 
bacteria specific antibody, and DAPI to study artificial bacterial mixtures with fluorescence 
microscopy 14.  
In the present study, faecal samples of healthy individuals were hybridised with CY5 labeled 
16S rRNA targeted oligonucleotide probes specific for four of the major faecal bacterial 
populations, followed by staining with R-PE labeled anti-Hu IgA and analysed by flow 
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cytometry. We show that flow cytometric analysis of FISH is more sensitive than image 






Materials and methods 
 
Volunteers and sample preparation 
Faeces was collected from ten healthy volunteers, 6 males and 4 females, aged 18-65 years 
(median 41 years). Exclusion criteria were: immunocompromised conditions (corticosteroids, 
diabetes, etc.), significant comorbidity, antibiotic use less than two weeks before sampling, 
diarrhoea and pregnancy. Each faecal sample was frozen within three hours after defaecation 
and stored until use at -20°C. For analysis half a gram of faeces was thawed, suspended in 4.5 
ml phosphate buffered saline (PBS, pH=7.2), homogenized on a Vortex mixer during 1 min 
and centrifuged at low speed (700g, 20 min) to separate large faecal particles from bacteria. 
One ml of supernatant was centrifuged at 8000g for 10 minute to remove non-bound faecal 
immunoglobulins. The pellet was resuspended in 1 ml PBS and 100 µl of this suspension 
(nonfixed bacteria) was stored until use at -20°C. The rest of the bacteria was fixed and 
permeabilised with fresh paraformaldehyde (PFA) at a final concentration of 3% (w/v) at 4°C 
for 16 hours. The fixed bacteria were washed twice with 1 ml PBS and the final pellet was 
resuspended in 1 ml of a cold mixture (50:50, v/v) of ethanol 96% and PBS and kept at least 
one hour at -20°C. For image analysis, these ethanol / PFA fixed bacteria were further diluted 
in PBS (1:10 v/v) and then 10 µl was put on a microscopic slide and air dried 1. 
 
Study design 
For fluorescent in situ hybridisation (FISH), all 10 PFA/ethanol fixed faecal samples were 
analysed by flow cytometry and image analysis (the 'gold standard'). For flow cytometry all 
analyses of each sample were carried out simultaneously in which a maximum of 36 samples 
were analysed. For determination of the bacterial immunoglobulin coating, fixed and nonfixed 
(the 'gold standard' 11) samples were analysed by flow cytometry. All solutions used in this 
study were filtered (0.22 µm Millepore, Molsheim, France). In order to determine the variation 
of flow cytometry analysis between assays, replicate analyses of one single faecal sample were 
included in each series of measurements (n=25). Furthermore, in one series of experiments, a 
faecal sample was hybridised 6 times and analysed to estimate the intratest variability.  
 
Fluorescence in situ hybridisation (FISH) 
Flow cytometry: 2 µl PFA/ethanol fixed bacterial suspension (containing approximately 108 
bacteria) was hybridised at 50°C for 16 hours in 100 µl hybridisation buffer (20 mM Tris-HCl, 
pH=7.2, 0.1% sodium dodecyl sulfate, 0.9 M NaCl) and 1-5 ng oligonucleotide Cy5 labelled 
probe/µl. In serial dilution experiments the optimal probe concentration was found to be: 1 
ng/µl for EUB338 (a probe with specificity for nearly all bacteria) 6 and ELGC01 (for the 
eubacteria low G+C #2 group (ELGC-group)) 15, 2 ng/µl for ATO291 (Atopobium-group) 16 and 
5 ng/µl for EREC482 (Clostridium coccoides and Eubacterium rectale group (EREC-group)) 1 
and BIF164 (bifidobacteria ) 17. The concentration of the nonspecific probe nonEUB338 (does 
not hybridise with any known bacterium) was 1 ng/µl for EUB338 and ELGC01, 2 ng/µl for 
ATO291 and 5 ng/µl for EREC482. After hybridisation, 1 ml washing buffer (50°C, 
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hybridisation buffer without sodium dodecyl sulfate) was added and after centrifugation (10 
min 14,000g) the pellet was resuspended in 1 ml of washing buffer (50°C) and incubated for 
20 min at 50°C. This suspension was then centrifugated and the pellet was resuspended in 200 
µl cold (4°C) SYBR Green I / PBS (1:60,000 w/v), stored on ice in the dark and analysed 
within two hours. 
Microscopic slides: Air-dried PFA/ethanol fixed (see above) faecal suspensions were mounted 
on a microscopic glass and incubated with 5 ng oligonucleotide probe (the same probes as used 
for flow cytometry) /µl hybridisation buffer at 50°C for 16 hours. The slides were then 
incubated in washing buffer for 20 min at 50°C, dipped in distilled water and rapidly dried 
with a flow of compressed air. The sections were mounted with Vectashield (Vector 
Laboratories, Burlingame, Calif.) 1. The instrumentation has been described in detail elsewhere 
1, 5
. Briefly, a microscope was used equipped with phase-contrast, a mercury vapor lamp, a CCD 
camera, and an application image analysis software program. Per sample at least 1000 bacteria 
were analysed. 
 
Immunofluorescence combined with FISH 
To determine the percentage of specific bacteria coated with IgA, the hybridised bacteria (see 
above) were resuspended in 60 µl of affinity-purified Rhodamine-Phycoerythrin- F(ab)2 anti-
Hu IgA (1% in BSA / PBS (1% (w/v)) (Southern Biotechnology Associates, Birmingham, AL) 
as well as BSA / PBS (1% (w/v)) as a control. After a 30 min incubation period (20°C), 
suspensions were washed twice with cold (4°C) PBS. Finally, the bacterial pellet was 
resuspended in 200 µl cold SYBR Green I / PBS (1:60,000 w/v), stored on ice in the dark and 
analysed within two hours. To determine the influence of fixation and the FISH procedure, 
nonfixed faecal bacterial suspensions were stained with R-PE- F(ab)2 anti-Hu IgA (1% in BSA 
/ PBS (1% (w/v)) and PBS / BSA (1% (w/v)) according to the protocol above. 
 
Flow cytometry 
Flow cytometry was performed with an EPICS - ELITE (Coulter - Electronics, Hialeah, Fl) 
equipped with an Argon ion laser and a Helium-Neon laser. The 488-nm emission line of the 
first laser, with an output of 15 mW, was used for forward-angle light scatter (FSC) and right-
angle light scatter (SSC) as well as SYBR Green I and Rhodamine-Phycoerythrin (R-PE). The 
Helium Neon laser was used for CY5. Filtersettings were 525 BP for SYBR Green I, 675 BP 
for Cy5, and 575 BP for R-PE.  
Since a considerable fraction of the faecal bacteria is smaller than 1 µm 11, FSC or SSC cannot 
be used as a discriminator 11. Previously we used propidium iodide (PI) to stain all bacteria. To 
avoid quenching we now used three fluorochromes with minimal overlap in emission and 
excitation spectra: the nucleic acid stain SYBR Green I (Molecular Probes, Eugene, OR) to 
stain all bacteria, Cy5 as a label for the oligonucleotide probes and R-PE as a label for the 
antibodies. The discriminator was set on SYBR Green I fluorescence as a specific stain for 
bacteria. The discriminator value was determined by a bacteria-free solution of SYBR Green I 
in PBS (1:60,000 w/v) and set at a level with minimal background noise. Analysis was 
performed with 20,000 events, at a flow rate of 1000 events / sec. The fluorescence was 
recorded logarithmically, FSC linearly. Acquisition and data analysis were done with standard 
ELITE software comprising the Immuno-4 program to determine the percentage of stained 
events. An additional gate was set to exclude events with very large FSC (agglutinated 
bacteria). 
To determine the percentage of hybridised bacteria the CY5-fluorescence histograms of the ten 
faecal suspensions that were hybridised with a specific probe were subtracted by the CY5-
fluorescence histograms of the same faecal suspensions hybridised with non-EUB338 (in the 
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identical concentration as the specific probe) by matched region subtraction 18. 
To determine the percentage of IgA-coated bacteria within each of the bacterial populations, 
each fixed faecal suspension was divided into 8 portions. These were hybridised with four 
(EUB338, EREC482, ATO291, BIF164) CY5-labeled rRNA targeted probes (2 portions each). 
Four portions (one with each probe) were additionally stained with R-PE-anti-Hu-IgA, and as a 
control the other 4 were only incubated with PBS/BSA (1%). After flow cytometry analysis, 
the bacterial population that hybridised with the probe was selected by a life gate and R-PE-
fluorescence (=IgA) histograms of this selected population were made. To determine the 
percentage of IgA-coated bacteria of this bacterial population, the R-PE-histogram of the IgA-
stained portion was subtracted by the R-PE-histogram of the control (non-IgA stained) portion 
of the faecal suspension. The percentage of IgA-stained bacteria of each population was 
determined by ‘matched region subtraction’ 18. As a control the 10 faecal suspensions were 
stained with R-PE-anti-Hu-IgA without the FISH procedure. 
 
Statistical analysis 
Since a normal distribution of the data could not be proven, the Wilcoxon signed rank test was 
used to test differences. Simple regression was used to test possible correlation between data 




















Figure 1. Flow cytometric analysis of a faecal suspension hybridised with EUB338-Cy5 (1b) and non-
EUB338-CY 5 (1c). As shown in a forward scatter (FSC) - side scatter (SSC) scatterplot (1a), a gate was 
set to exclude events with very large FSC (large aggregates of bacteria). The discriminator was set on 
SY BR Green I fluorescence as a specific stain for bacteria (1bc). EUB338-CY 5 hybridisation resulted 
in a diffuse staining pattern of a large population of bacteria that could be separated from bacteria that 
did not hybridise (along the y-axis) (1b). Nonspecific fluorescence (autofluorescence in combination 
with nonspecific probe binding as determined with nonEUB338-CY 5) was minimal (1c). 
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Flow cytometric analysis and image analysis 
EUB338 is a rRNA probe with specificity for almost all bacteria 6. Thus, it hybridises with a 
very heterogeneous population of small and large, well-hybridising and not-well-hybridising 
bacteria. This was reflected in a diffuse staining pattern and less than 100% hybridisation 
efficiency (fig 1b). Though, hybridised bacteria could be distinguished from bacteria that did 
not hybridise (fig 1b). To determine the percentage of bacteria that hybridised with EUB338, 
the CY5-fluorescence histograms of the ten faecal suspensions were matched with the 
histograms of the same suspensions that hybridised with nonEUB338 and subtracted by 
matched region subtraction 18 (fig 2). Herewith, 71.9% (±13.2%) of the SYBR Green I stained 






















Figure 2. CY 5-fluorescence histogram of a faecal suspension hybridised with CY 5-EUB338 (2a, dotted 
line) was matched with the histogram of the same suspension hybridised with CY 5-nonEUB338 (2a, 
continuous line) and subtracted by matched region subtraction 18. The matched region (A), the region in 





Clostridium coccoides Eubacterium rectale group (EREC-group) comprises a very 
heterogeneous population of bacteria which is reflected in a diffuse staining pattern 
comparable to EUB338 (fig 3ab). In contrast, the three other bacterial groups had distinct 
homogenous populations in SYBR Green I - probe-CY5 scattergrams (fig 3ac, 4a, 5a).  
Flow cytometric analysis and image analysis of identical faecal samples gave different results: 
with image analysis eubacteria low G+C #2 group could be identified in 9/10 samples 
compared to 3/10 with flow cytometry (Table 1). On the other hand, flow cytometric analysis 
resulted in significantly higher percentages of bifidobacteria and bacteria of the Clostridium 
coccoides and Eubacterium rectale group (Table 1). Despite these differences, there was a 




















Figure 3. Typical probe-SY BR Green I scatterplots of the same faecal suspension hybridised with 
EREC482-CY 5, nonEUB338-CY 5 or BIF164-CY 5. Hybridisation with EREC482-Cy5 revealed a 
relatively large population of bacteria of the Clostridium coccoides and Eubacterium rectale group (3a). 
This population was not well separated from nonspecific fluorescence (nonEUB338-CY 5, 3b) 
presumably due to the heterogeneity of the Clostridium coccoides and Eubacterium rectale group. In 

























Figure 4. Probe-SY BR Green I scatterplots of a faecal suspension hybridised with ATO291-CY 5 (4a) 
or nonEUB338-CY 5 (4b). A  small distinct population of bacteria of the Atopobium-group could be 
identified. 
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Figure 5. Probe-SY BR Green I scatterplots of a faecal suspension hybridised with ELGC01-CY 5 (5a) 





Table 1.  Percentages (±sd) of bacteria that hybridised with 4 group -specific probes as determined with 
flow cytometry and image analysis. Flow cytometry data are expressed as a percentage of S YBR Green 
I staining bacteria, and as a computed percentage of EUB338 hybridising bacteria. Data obtained with 
image analysis are expressed as a percentage of EUB338 hybridising bacteria.  
 
 
probe EREC482 1 BIF164 2 ATO291 3 ELGC01 4  
 
Flow cytometry 
samples with population * 10/10 8 /10 9 /10 3 /10 
% of SYBR Green I 36.0±9.3% 6.2±5.6% 5.0±3.7% 3.4±0.5% 
% of EUB338 52.3±18.9% 9.0±7.3% 6.7±4.6% 5.1±1.2% 
  
Image analysis 
samples with population 10/10 10/10 10/10 9 /10 
% of EUB338 19.3±7.1% ** 3.6±4.3% ** 5.5±2.9% 9.6±8.9% 
  
correlation (R2)*** p=0.11 (26%) p=0.001 (76%) p=0.06 (37%) - 
 
 
1 Clostridium coccoides and Eubacterium rectale group, 2  bifidobacteria,  3  Atopobium-group,   
4  eubacteria low G+C #2 group  
* Number of samples in which a specific bacterial population could be identified.  
** Significantly lower than flow cytometry 
*** Simple regression analysis was used to test possible correlations between data obtained with flow 







Flow cytometric analysis of FISH of faecal samples  
Since many faecal bacteria are smaller than 1 µm, FSC or SSC cannot be used as a 
discriminator. In the present study, three fluorochromes with minimal overlap in emission and 
excitation spectra were chosen: the nucleic acid stain SYBR Green I to stain all bacteria, Cy5 
as a label for the oligonucleotide probes and R-PE as a label for the antibodies. By serial 
dilutions the optimal SYBR Green I concentration was found to be 1:60,000 w/v in PBS. The 
discriminator was set on SYBR Green I fluorescence to detect bacteria. Herewith, bacteria 
could be clearly discriminated from background noise (fig 1b). All events with a large forward 
scatter (FSC), i.e. large aggregates 11 were excluded from final analysis (fig 1a).  
Nonspecific fluorescence of bacteria can be due to both autofluorescence and nonspecific 
binding of fluorescent probes or antibodies. All bacteria contain molecules with 
autofluorescent properties characterised by a broad spectrum of wavelengths with low 
amplitude. As a control for nonspecific probe-binding all samples were hybridised with CY5-
nonEUB338 (a nonsense probe that does not hybridise with any known bacteria). Compared to 
autofluorescence hybridisation with CY5-nonEUB338 resulted in minimal extra CY5 
fluorescence and, thus, nonspecific binding of the probes was not an important phenomenon 






















Figure 6. Nonspecific CY 5-fluorescence as determined with flow cytometry analysis of a faecal 
suspension without probe (i.e. autofluorescence) (6a) and hybridised with a nonsense probe 
(nonEUB338-CY 5) (6b). Most bacteria had low levels of autofluorescence (6a). Nonspecific -




To determine the intertest variability the same faecal sample was analysed for the presence of 
bifidobacteria in 25 different experiments. In all analyses a discrete population of 
bifidobacteria could be identified (fig 1ab). The mean (± sd) percentage of bifidobacteria was 
5.45 ± 0.60 and, thus, the coefficient of variation of the intertest variability was 11 %. In one 
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series of experiments this faecal suspension was hybridised 6 times. The mean (± sd) 
percentage of bifidobacteria was 5.12% (±0.32%) and, thus, the coefficient of variation of the 
intratest variability was 6.3 %. 
During the staining procedure for flow cytometry 6 washing steps were needed: 2 for fixation, 
2 for FISH and 2 for immunofluorescence. To determine the possible loss of bacteria due to the 
washing procedure and FISH procedure, two samples were divided into two fractions. One 
fraction was fixed and washed twice, the other underwent the complete FISH procedure. The 
resulting bacterial suspensions were then coated onto a slide, stained with DAPI, and counted 
for the number of bacteria present in 10 microscopic fields. Herewith, we found that the total 
number of bacteria decreased with 28% due to the FISH procedure and the 4 additional wash 
steps. 
 
Flow cytometric analysis of FISH combined with IF of faecal bacteria  
To test whether there is a preference IgA-coating of certain bacterial populations in faeces we 
developed a flow cytometric method that combines FISH with immunofluorescence. To 
compare our method with former studies in which another set of fluorochromes were used 19, 
and to determine the influence of the procedure, we first analysed nonfixed bacteria stained 
with R-PE-labeled anti-Hu IgA that were not subjected to the FISH procedure. With this new 
combination of fluorochromes, the percentage of IgA-coated faecal bacteria present in faecal 
suspensions of 10 healthy individuals was 32.6 % (±8.5%). 
The combination of FISH with immunofluorescence resulted in a significant decrease of the 
percentage bacteria coated with IgA from 32.6 % (±8.5%) to 12.6 % (±4.7%) (p< 0.005). 
Reversing the order of both techniques (i.e. IgA staining prior to FISH) had no influence (data 
not shown). The addition of the immunofluorescence staining procedure did not influence the 
probe hybridisation (data not shown). 
In conclusion, FISH can be combined with immunofluorescence, however, at the expense of a 
considerable loss in sensitivity of the immunofluorescence. 
 
Increased IgA-coating of bifidobacteria 
To determine the percentage of IgA-coated bacteria within the various FISH-defined bacterial 
populations, each fixed faecal suspension was divided in 8 portions: 4 portions were hybridised 
with one of the four (EUB338, EREC482, ATO291, BIF164) CY5-labeled rRNA targeted 
probes and additionally stained with R-PE-anti-Hu-IgA. As a control, the other four portions 
were also hybridised with one of the four probes and additionally incubated with PBS/BSA 
(1%). After flow cytometry analysis, the bacterial population that hybridised with the probe 
was selected by a gate within a CY5-fluorescence-SYBR Green I scatterplot (fig 7a) and R-PE-
fluorescence (=IgA) histograms of this selected population were made. To determine the 
percentage of IgA-coated bacteria of this bacterial population, the R-PE-histogram of the IgA 
stained portion was subtracted by the R-PE-histogram of the control (PBS/BSA incubated) 
portion of the faecal suspension (fig 7b). The percentage of IgA-stained bacteria, as determined 
by matched region subtraction, of most bacterial populations were identical: 12.6 % (±4.7) of 
the SYBR Green I stained bacteria, 11.9% (±6.8) of the EUB338, 9.2% (±4.9) of the 
Clostridium coccoides and Eubacterium rectale group, and 13.3% (±6.7) of the Atopobium-
group were coated with IgA. In contrast, 29.5% (±19.8) of the bifidobacteria (p<0.05 with all 
bacterial populations) were coated with IgA. These data show that there is an increased IgA-



























Figure 7. The percentage of IgA-coated bifidobacteria as determined by three color flow cytometry: two 
portions of each faecal suspension were hybridised with BIF164-CY 5 and additionally stained with R-
PE-anti-Hu-IgA or PBS/BSA (control). A fter flow cytometry analysis bifdobacteria (BIF164) were 
selected by a life gate within a CY 5-fluorescence - SY BR Green I scatterplot (7a), and R-PE-
fluorescence (=IgA) histograms of this selected population were made. To determine the percentage of 
IgA-coated bacteria of the bifidobacteria, the R-PE-histogram of the IgA stained portion (7b, Overlay, 
dotted line) was subtracted by the R-PE-histogram of the control (PBS/BSA) portion (7b, Overlay, 
continuous line). The percentage of IgA stained bifidobacteria was determined by matched region 




Flow cytometric analysis of FISH of faecal samples  
We describe a new flow cytometric method to analyse whether all bacteria are similarly coated 
with IgA. We used a combination of SYBR Green I (to stain all bacteria), FISH with CY5-
rRNA-targeted probes directed to either all bacteria (EUB338), or probes specific for certain 
groups of bacteria (Clostridium coccoides and Eubacterium rectale group, bifidobacteria, 
Atopobium-group, eubacteria low G+C #2 group), as well as a nonsense probe (nonEUB338) 
in combination with immunofluorescence (R-PE-anti-Hu IgA). With this new method we 
analysed ten faecal samples of healthy humans. In order to validate FISH as analysed with flow 
cytometry, all ten faecal samples also were subjected to FISH on a microscopic slide and were 
analysed with image analysis 1,5.  
Our flow cytometric method can specifically identify bacterial groups within faecal 
suspensions because: (a) the probes used are specific for certain bacterial groups, (b) 
autofluorescence and fluorescence due to nonspecific binding of the probe has been subtracted 
from the fluorescence signal of the hybridised bacteria, (c) the method is reproducible with a 
coefficient of variation of the intertest variability of 11 %, (d) the percentages of bifidobacteria 
and bacteria of the Atopobium-group within faeces as determined by flow cytometry correlated 
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with the data obtained with image analysis.  
The percentage of bifidobacteria as determined by flow cytometry was higher than with image 
analysis. Theoretically, this difference between both methods can be explained by a loss of 
EUB338 hybridising bacteria (but selectively not bifidobacteria) due to the flow cytometric 
sample preparation. Though some bacteria were lost during sample preparation, the mean 
forward scatter of the bacteria did not change suggesting that there was no bias towards 
bacteria with a certain size, and, thus, presumably no preferential loss of certain bacterial 
groups. A greater sensitivity of flow cytometry for the identification of bifidobacteria could 
theoretically also explain the higher percentage of bifidobacteria determined by flow cytometry 
analysis compared to image analysis. An argument for a greater sensitivity of FISH when 
analysed by flow cytometry may be that with flow cytometry we found higher percentages of 
the Clostridium coccoides and Eubacterium rectale group (52.3±18.9%) compared to image 
analysis in both the present study (19.3±7.1%) and a former study (22.7%) 5 and a higher 
percentage of EUB338 hybridising bacteria (71.9%±13.2%) compared to a former study with 
image analysis (60.9%) 5. This greater sensitivity of flow cytometry may be explained by the 
histogram subtraction method we used for our flow cytometry data 18. Due to the heterogeneity 
of the faecal bacterial population there is a considerable overlap in fluorescence levels between 
(a) bacteria with the strongest autofluorescence and no specific fluorescence and (b) bacteria 
with weak autofluorescence combined with weak specific fluorescence. With ‘matched region 
subtraction’ 18 bacteria with weak specific fluorescence can be identified. In contrast, for image 
analysis a threshold is arbitrarily set at a level above the level of strongest autofluorescence.  
In contrast, image analysis appeared more sensitive for the eubacteria low G+C #2 group. With 
flow cytometry in 3 out of 10 samples an eubacteria low G+C #2 group population could be 
recognised, compared to 9 out of 10 with image analysis. Most of these 9 populations were 
large enough (i.e. larger than approximately 2%) to be recognised by flow cytometry. An 
explanation may be that hybridisation with the ELGC01 probe is less stable than with the other 
probes tested and, thus, that hybridisation was lost during the washing steps with PBS.  
Compared to image analysis, flow cytometry has advantages as well as disadvantages. 
Advantages are the speed of analysis, the large number of bacteria that can be analysed 
(100,000 in 1 minute), the greater sensitivity due to histogram subtraction of nonspecific 
fluorescence, and the possibility to combine FISH with immunofluorescence. Disadvantages 
are the laborious sample preparation, the need of an extra fluorochrome, the inability to analyse 
small (i.e. smaller than approximately 2%) bacterial populations whereas with image analysis 
even populations smaller than 0.01% can be accurately analysed, and hybridisation with some 
probes may disappear during the sample preparation. 
 
Increased IgA-coating of bifidobacteria 
Our data show a higher percentage of IgA coating of bifidobacteria compared to the other 
bacterial groups tested. This may be the result of selective IgA coating of certain subtypes of 
bifidobacteria, or by a general increase in the number of IgA molecules coated to the 
bifidobacteria resulting in a higher percentage of bifidobacteria above the detection limit of this 
flow cytometric method. The increase in IgA coating can thus be caused by: (a) nonspecific 
IgA coating to bifidobacteria, for instance via carbohydrate side chains that are present on IgA 
20-22
, or by (b) specific IgA coating of bifidobacteria. If this latter assumption is true, then this 
increased IgA-coating of bifidobacteria may be either explained by an increased interaction 
between the mucosal immune system of the gut and these bacteria or a loss of mucosal 
tolerance for these bacteria. What can be the consequence of an increased bacterial IgA-coating 
within the intestinal lumen ? Intestinal epithelial cells are covered by a mucus gel that contains 
large amounts of IgA 20. Within this mucus layer there are no bacteria 23. This is surprising in 
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view of the large amount of bacteria close to this mucus layer. Bacterial IgA-coating may 
hinder bacteria passing the viscous mucus layer by (a) increased binding of bacteria to the 
mucus layer 22 presumably via binding of the carbohydrate side chains of IgA to the mucus, (b) 
agglutination of bacteria within mucus, and (c) inhibition of bacterial motility by binding to 




In conclusion, we describe a new flow cytometric method to analyse bacterial populations 
within faeces with a FISH technique that detects the IgA-coating of faecal bacterial 
populations. This technique may be more sensitive than image analysis for analysis of large 
bacterial populations with a stable hybridisation, but less sensitive for small bacterial 
populations or probes with instable hybridisation. With flow cytometry an increased IgA-
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Background. The commensal intestinal microflora has important metabolic and perhaps also 
immune modulatory functions. Evidence accumulates that the microflora plays a role in the 
pathogenesis of inflammatory bowel disease. Therefore, there is a growing interest in the 
intestinal microflora and its interaction with the host. Presumably, this interaction takes place 
at the mucus layer. In this study we investigated the microflora that is present at the mucus 
layer and addressed the following questions: (1) does a specific mucus-adherent microflora 
exist ? and (2) is there direct contact between commensal bacteria and epithelial cells ?  
 
Methods. Snapfrozen biopsies were taken of 5 colon regions and of the terminal ileum of 9 
subjects with a normal colon. Faecal samples were also collected. Bacteria were detected in 
cryosections with fluorescent in situ hybridization (FISH) with 16S rRNA-targeted probes for 
all bacteria and specific probes for the major representatives (together quantitatively 70% of 
the bacteria) of the anaerobic microflora (bifidobacteria, Bacteroides, clostridia, atopobia) and 
aerobic microflora (Enterobacteriaceae, enterococci, streptococci, lactobacilli).  
 
Results. With this sensitive technique bacteria were only observed at the lumenal side of the 
intestinal mucus layer. Very few microcolonies were present at the mucus layer and the 
composition of the bacterial microflora present in the faeces was similar to that at the mucus 
layer of the terminal ileum and colon regions.  
 
Conclusions. The equal distribution of bacterial species suggests that intestinal commensal 
bacteria live in suspension in the lumen and that there is no specific mucus-adherent 
microflora. We did not observe direct contact between bacteria and epithelial cells. 
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The human intestinal tract harbors a complex microbial ecosystem, usually referred to as the 
normal commensal microflora. This microflora consists mainly (>99.9 %) of obligatory 
anaerobic bacteria. The highest bacterial concentrations are found in the colon and terminal 
ileum: 1010 - 1012 bacteria per gram intestinal content. Each individual has a characteristic 
commensal colon microflora that is relatively stable over time 1. The normal microflora has 
many beneficial functions: synthesis of vitamin K and growth factors for host intestinal cells, 
prevention of outgrowth of potentially pathogenic bacteria (colonization resistance), 
stimulation of intestinal motility, promotion of the enterohepatic circulation by deconjugation 
of bile acids, stimulation and maturation induction of the gut immune system and modulation 
of the expression of a number of epithelial genes 2-4. The intestinal microflora, however, also 
plays a role in the pathogenesis of inflammatory bowel disease, especially Crohn’s disease 5. 
Modulation of the microflora with antibiotics, probiotics or diet may induce a remission in 
inflammatory bowel disease 5,6. Furthermore, there are many animal models that spontaneously 
develop a colitis, unless they are kept germ free 7. For all these reasons, there is a growing 
interest in the intestinal microflora and its interaction with the host. 
How this interaction between the host and its commensal intestinal microflora takes place is 
not known. Theoretically, there are several possible mechanisms: (a) commensal bacteria may 
influence the mucosal immune system indirectly via uptake of whole bacteria or their 
fragments by either M cells, dendritic cells that send dendrites into the mucus layer, or via 
passive penetration of whole bacteria into the mucosa via incidental defects in the epithelial 
lining and mucus layer (e.g. due to a viral enterocolitis) 8, 9, (b) commensal bacteria may affect 
epithelial cells directly via epithelial Toll like receptors with affinity for bacterial cell wall 
components 10-12 or via small ‘soluble signals’ that diffuse through the gelatinous mucus layer 13, 
14
. Commensal bacteria that are responsible for the interaction with the host are expected to be 
in close vicinity with the epithelial cells and the mucosal immune system: these bacteria may 
be present within the mucus layer or be attached to epithelial cells. It is commonly believed 
that the composition of the bacterial microflora within the mucus layer differs from the 
microflora in the intestinal lumen 15, 16. An adherent bacterial population, if it exists, needs the 
capability to attach to the mucus layer or to epithelial cells and multiply within the mucus and, 
thus, form microcolonies. In contrast, lumenal bacteria must be capable to multiply under the 
strict anaerobic conditions within the lumen and be able to degrade lumenal fibers and other 
remnants and use these as nutrients. 
In the present study, we investigated the commensal bacterial microflora that is present at the 
mucus layer and within the lumen of colon and terminal ileum. For this purpose, we examined 
biopsies of five regions of the colon and the terminal ileum of 9 patients with a macroscopic 
and microscopic normal colon. In order to preserve the mucus layer, the biopsies were 
snapfrozen. The bacteria present in the sections of the biopsies were detected with a sensitive 
technique: fluorescent in situ hybridization (FISH) with 16S rRNA-targeted oligonucleotide 
probes directed to all bacteria, in combination with probes specific for the major 
representatives of the anaerobic and aerobic microflora.  
In the present study we show that commensal bacteria are only present at the lumenal side of 
the mucus layer and do not have direct contact with epithelial cells. In each subject, the 
composition of the bacterial population residing at the mucus layer was identical to that in the 
lumen and no regional differences were found. In contrast to the common belief, these results 
suggest that intestinal commensal bacteria live in suspension in the lumen and do not 
specifically adhere to the mucus layer or to epithelial cells. 
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Materials and methods 
 
Patients 
Patients (aged 18-65 yrs, 6 males and 3 females) that underwent a colonoscopy, with as 
indication anemia (n=4) or abdominal pain (n=5), were asked to participate in the study. These 
patients had no comorbidity, did not use antibiotics within the past 4 weeks and had no 
macroscopic or microscopic abnormalities in colon and terminal ileum. Their bowel was 
prepared by drinking 4 liters of lavage fluid (Klean-Prep) containing polyethyleneglycol within 
16 hours. In order to obtain biopsies from an unprepared colon, the bowel of two additional 
patients (mean age 55 yr, 1 male) was prepared with an enema and the colonoscope was 
introduced into the proximal colon, a fecal contaminated region that was not reached by the 
enema. One healthy subject (male 35 yr) donated a fresh solid fecal sample. The present study 
was approved by the local medical committee. 
 
Sample collection and fixation 
From each of the nine colonoscopy patients twelve biopsies were taken: two biopsies from 5 
different colon regions (rectum, sigmoid colon, transverse colon, ascending colon and cecum) 
and two from the terminal ileum. Furthermore, a fresh fecal sample was collected from each 
patient and stored at –20° C. From each of the two patients with an unprepared colon 4 
biopsies were taken out of a part of the colon with the feces in situ (ascending colon). All 
biopsies were snapfrozen within 10 minutes. Cryosections (8 µm) were airdried at room 
temperature and fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for 16 
hours at 4°C, washed in PBS and then fixed 10 min in ethanol 96%.  
Of each fecal sample 0.5 gram was suspended in 4.5 ml of filtered (0.2 µm pore size filter) 
PBS and vortexed with glass beads for at least 3 min to homogenize the fecal sample. The 
suspension was centrifuged at 700 x g for 1 min to remove debris. The supernatant was fixed in 
4% paraformaldehyde at 4°C for 16 hours and stored in 50% (vol/vol) ethanol-PBS at –20° C 
until further use 1,5. The fixed supernatants were diluted in PBS to a concentration at which 
approximately 100 bacteria could be seen through the microscope per high powerfield. Of 
these suspensions 10 µl was mounted on eight different slides and dried at room temperature.  
The solid fecal sample was fixed in 4% paraformaldehyde for 5 days at 4°C followed by 
ethanol 96% for 24 hours and then embedded in paraffin. Sequentially numbered 8 µm sections 
were made, deparaffinised with xylol 100% and washed in 96% ethanol before use. 
 
FISH procedure 
FISH was performed on biopsy sections, fecal suspensions and sections of the solid fecal 
sample. Sections and fecal suspensions were hybridised with a mixture of rhodamine-labeled 
BACT338 probe 17 with specificity for all bacteria (including Helicobacter spp) in combination 
with one out of eight different fluorescein-labeled group-specific 16S rRNA-targeted 
oligonucleotide probes: ATO291 for Atopobium–group 18, BIF164 for bifidobacteria 19, 
ELGC01 for Eubacteria low G+C #2 group 20, EREC482 for Clostridium coccoides and 
Eubacterium rectale group 1, BAC303 for Bacteroides and Prevotella 21, ENTB1458 for 
Enterobacteriaceae 22, LAB158 for lactobacilli and enterococci 23, STREP493 for streptococci 
and lactococci 1. Furthermore, in each experiment appropriately pure cultured bacteria were 
hybridised as a positive control of the FISH procedure. Gram positive bacteria have an 
impermeable cell wall. Therefore, some sections were pretreated with lysozyme (2 mg 
lysozyme / ml 100 mM TRIS-HCl, pH=8.5, 37° C). One section of each biopsy was incubated 
with lysozyme for 15 minutes which permeates the cell wall of enterococci, streptococci and 
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lactococci, but not lactobacilli. This section was hybridised with a mixture of LAB158 and 
STREP493 in addition to the BACT338 probe. A second section of each biopsy was incubated 
with lysozyme for 75 minutes. This treatment permeates the cell wall of lactobacilli but 
severely damages enterococci in a way that they do not hybridise with the LAB158 probe. This 
section was hybridised with LAB158 in addition to the BACT338 probe. Sections and fecal 
suspensions were incubated with 5 ng oligonucleotide probe / µl hybridisation buffer (20 mM 
TRIS-HCl, pH=7.2, 0.1% sodium dodecyl sulfate. 0.9 M NaCl) at 50°C for 3 hours (BAC303 
and ENTB1458) or 16 hours (all other probes). Sections and fecal suspensions were then 
subsequently washed with hybridisation buffer without sodium dodecyl sulfate for 20 min at 
50 ° C, dipped in distilled water and rapidly dried with a flow of compressed air. The sections 
were mounted with Vectashield (Vector Laboratories, Burlingame, Calif.). 
 
Mucus staining 
To determine the intactness and thickness of the mucus layer, a fixed section of each biopsy 
was stained with alcian blue and evaluated by light microscopy. In order to specifically stain 
both the mucus layer and bacteria in the same section, some sections (not of all patients) 
underwent sequential staining with the FISH procedure (rhodamine-BACT338) followed by a 
wash with PBS and immunofluorescence (affinity-purified FITC-polyclonal goat-F(ab’)2- anti-
Hu IgA, 1:100, 1% bovine serum albumin, 30 min, 20°C).  
 
Biopsy sections hybridised with fluorescent probes 
Of each biopsy, eight sections were double hybridised with a mixture of BACT338-rhodamine 
and one of the eight different fluorescein-labeled group-specific probes. Each section was 
thoroughly evaluated by epifluorescence microscopy. This microscopic analysis was 
performed by three different observers. In the biopsies bacteria could be detected by their 
rhodamine fluorescence due to hybridisation with the BACT338 probe. Eukaryotic cells within 
the biopsy as well as the mucus layer could be clearly seen without any specific staining 
procedure due to their autofluorescence. To determine the spatial relation of commensal 
intestinal bacteria to the host, each section was evaluated for the presence of bacteria in the 
mucus layer, adhering to the epithelial cells, in crypts or in the lamina propria.  
Within the same eight sections of each biopsy the percental and spatial distribution of the 
different bacterial groups was investigated. In each section if possible at least 200 bacteria 
(hybridising with BACT338-rhodamine) were evaluated for double hybridisation with a 
fluorescein-labeled group-specific probe and the percentage of the fluorescein-labeled bacteria 
was calculated. The whole section was investigated for the spatial distribution of the different 
bacterial groups in relation to the other bacteria. Clusters of fluorescein-labeled bacteria were 
regarded as microcolonies. 
 
Fecal suspensions hybridised with fluorescent probes 
The fecal suspensions that were mounted on eight different slides were hybridised with a 
mixture of BACT338-rhodamine and one of the eight different fluorescein-labeled group-
specific probes. At least 400 bacteria that stained with BACT338-rhodamine were evaluated by 
epifluorescence microscopy for double hybridisation with the fluorescein-labeled group-
specific probe and the percentage of the fluorescein-labeled bacteria was calculated. 
 
Solid fecal sample hybridised with fluorescent probes 
Sections of the solid fecal sample were hybridised with the eight different fluorescein-labeled 
group-specific probes. Each section was investigated by epifluorescence microscopy for the 





Data are presented as mean ± sd. The distribution of the percentages of bacteria that hybridised 
with the different probes did not significantly deviate from normality. The means were 







Preservation of the mucus layer 
The aim of the present study was to determine the spatial relation of the commensal intestinal 
bacterial microflora to the host. Therefore, we attempted to preserve the fragile mucus layer by 
making cryosections. Of each biopsy, only the undamaged center part was evaluated. Alcian 
blue stained sections revealed that all biopsies had an intact mucus layer (fig 1). In both colon 
and terminal ileum the crypts were completely filled with mucus. In the terminal ileum the 
sides of the villi facing the lumen were covered by a thin continuous mucus layer (±10 µm) 
(fig 1a). The colon had a thicker flat mucus layer (79 ± 40 µm) (fig 1b). The thickness of the 



















Figure 1. Terminal ileum (fig 1a, left picture) and colon (fig 1b) stained with alcian blue. In the 
terminal ileum the mucus (blue) fills most of the space between the villi. The lumenal side of the villi is 
covered with a thin mucus layer. The colon wall is covered with a thick flat mucus layer and also the 




The spatial relation of the commensal intestinal bacterial microflora to the host  
In colon and terminal ileum biopsies the intestinal cells and mucus layer could be clearly seen 
by epifluorescence microscopy without specific staining due to their faint autofluorescence. In 
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order to detect bacteria we used FISH with a rhodamine- or fluorescein-labeled probe that 
binds to all species (BACT338). Rhodamine- or fluorescein-stained bacteria showed colours 
that were different from the autofluorescent intestinal cells. Thus, technically bacteria could be 
detected within the mucosa. Bacteria were only detected at the lumenal side of the mucus layer 
(fig. 2 and 3). We did not detect bacteria at the epithelial side of the mucus layer, within crypts, 




Figure 2. Colon hybridised with 
rhodamine-BACT338 and fluorescein-
EREC482. The mucus (○) and 
epithelial cells are visible due to 
autofluorescence. Bacteria are only 
present at the lumenal side of the 
mucus layer. EREC482-hybridising 
bacteria (green and yellow (bright 
rhodamine and bright fluorescein 
results in yellow staining)) are 
randomly dispersed between the other 
bacteria (orange-red).  























Figure 3. Colon hybridised with rhodamine-BACT338 (FISH procedure) and stained with FITC-anti 
IgA (immunohistochemistry). Large amounts of IgA (green) are present in the mucus (○, fig 3ab), at the 
apical side of the epithelial cells and in plasma cells that are scattered within the lamina propria (fig 3a, 
left picture). The rest of the cells of the colon are darkred due to autofluorescence. Bacteria (orange-
yellow, arrow) are only present at the lumenal side of the mucus layer. Most of them are coated with 
IgA (fig 3b). Lumen = *. Bar = 50 µm (fig 3a), Bar = 10 µm (fig 3b) 
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In order to prove that the bacteria were present at the lumenal side of the mucus layer, some 
sections were stained with FISH (rhodamine-BACT338) followed by immunofluorescence 
(FITC-labeled anti-human IgA). Figure 3 shows a typical example of the IgA containing 
mucus layer with bacteria at the lumenal side. 
In 7 out of 108 biopsies, lymph follicles were present directly under the epithelial lining. The 
epithelial cells above these follicles were flattened suggesting the presence of M cells. Bacteria 
were not seen adhering to or present within these flattened epithelial cells. 
There was a large interindividual variation, but no regional variation, in the number of bacteria 
present in each section. One individual had only less than 5 bacteria per section in each biopsy. 
Three individuals had 100-200 bacteria per section. Whereas the sections of 3 other individuals 
contained over 200 (often more than 1000) bacteria per section. The biopsies taken from an 
unprepared colon had more than 1000 bacteria per section. 
 
The composition of the bacterial microflora present at the mucus layer of the colon and 
terminal ileum in comparison to the fecal microflora. 
If the composition of the bacterial microflora present at the mucus layer is different from the 
lumenal flora one would expect (1) microcolonies suggesting local multiplication of bacteria at 
the mucus layer and (2) a difference in composition of the bacterial microflora at the mucus 
layer compared to the lumenal (fecal) flora. Therefore, eight sections of each biopsy were 
double hybridised with a mixture of rhodamine-BACT338 and one of the eight different 
fluorescein-labeled group-specific probes. In nearly all sections the bacteria that hybridised 
with a group-specific probe, were scattered between the other bacteria (figure 2). Only in 7 out 
of 108 biopsies small microcolonies were found (figure 4). The microcolonies were found in 
the terminal ileum (3x), cecum, ascending colon, transverse colon and sigmoid. The 
microcolonies consisted of bacteria hybridising with EREC482 (3x), LAB158/STREP493 (2x), 
BAC303 and ATO291. The fact that only rarely microcolonies were detected at the mucus 
layer was not due to the bowel preparation since also microcolonies were absent within the 
biopsies taken from an unprepared region of the colon. Within each individual, the percentages 
of bacteria present at the mucus layer that hybridised with the 8 group-specific probes were 
identical to the percentages of the corresponding fecal suspensions (paired t-test). Furthermore, 
within each individual no regional (5 colon regions and terminal ileum) differences were found 
in the percentages of bacteria hybridising with the 8 group-specific probes (paired t-test) (data 
not shown). Table 1 shows the data of the 9 individuals for the terminal ileum, the pooled 
colon regions and the feces. Together these data suggest that there is no specific mucus-




Figure 4. Terminal ileum hybridised 
with rhodamine-BACT338 and 
fluorescein-STREP493. A  small 
microcolony (yellow, due to a 
combination of bright rhodamine and 
bright fluorescein ) of fluorescein-
STREP493 hybridising bacteria 
(streptococci or lactococci) is present at 
the lumenal side of the mucus layer 
between other bacteria (orange-red, 
arrow). Bar = 10 µm 
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Table 1. Mean (± sd) percentages of bacteria of the nine individuals that hybridised with group-specific 
probes. BACT338 = 100%.  
 
group-specific probe             terminal ileum         pooled colon regions          feces 
 
anaerobic bacteria 
EREC482                                    21 (±14)                      25 (±7)                        20 (±4) 
BAC303                                     19 (±16)                      20 (±13)                      17 (±11) 
ATO291                                         6 (±5)                          5 (±4)                            6 (±3) 
ELGC01                                         4 (±4)                          4 (±4)                            6 (±6) 
BIF164                                           4 (±6)                          4 (±7)                            4 (±8) 
 
facultative anaerobic bacteria 
LAB158/STREP493 15’ (*)           0.6   (±0.9)            0.7   (±0.4)                 1.4   (±1.6) 
LAB158 75’ (**)                           0.06 (±0.17)                  0.04 (±0.9)                 0.08 (±0.13) 
ENTB1458                                     not detected                 0.01 (±0.04)              0.02 (±0.03) 
 
*   15’: 15 minutes lysozyme pretreatment: mainly streptococci, lactococci and enterococci 
** 75’: 75 minutes lysozyme pretreatment: mainly lactobacilli  
 
Solid fecal sample 
Since only very few microcolonies were seen at the mucus layer we postulate that the 
replication of commensal intestinal bacteria takes place in suspension in the intestinal lumen. 
In the terminal ileum, cecum and ascending colon the lumenal contents is liquid whereas 
within the sigmoid and rectum the lumenal contents is more solid (feces). In order to determine 
whether there is local replication of bacteria within solid feces we performed FISH with the 8 
group-specific probes on sections of a solid fecal sample.  
Fibres of vegetable origin were scattered within the solid fecal sample. Most bacterial groups 
were diffusely dispersed. However, only with EREC482 microcolonies were seen, especially 
along vegetable fibers suggesting an interaction between bacteria and fibers (e.g. 
fermentation). Although only one solid fecal sample was investigated, these data suggest that 
only few bacterial species can multiply within solid feces. Thus, examination of fecal samples 
may be representative of the bacterial microflora within the whole colon and terminal ileum. 
 
 
Figure 5. Section of a solid fecal 
sample hybridised with fluorescein-
EREC482. A  band of EREC482 
hybridising bacteria (green, small 
arrow) is present along a vegetable 
fibre (line). Other EREC482 
hybridising bacteria are diffusely 
scattered throughout the solid fecal 
sample and do not form 






In this study we show that (1) in the terminal ileum and colon commensal bacteria are present 
at the lumenal side of the mucus layer and not in crypts or attached to epithelial cells; (2) the 
composition of the microflora at the surface of the mucus layer is similar at all anatomical 
locations (terminal ileum, cecum, ascending colon, transverse colon, sigmoid and rectum) and 
to feces (lumenal microflora); (3) only few microcolonies are present at the mucus layer which 
indicates that local multiplication of bacteria at the mucus layer is rare. Together, these data 
suggest that the commensal microflora lives and multiplies in suspension in the intestinal 
lumen and that there is no specific mucus-associated microflora. This contrasts with the 
common belief that there is a mucus-adherent and a non-adherent microflora in the intestine 15, 
16
.  
Thus, our findings suggest that bacterial multiplication occurs in liquid intestinal contents and 
will, thus, be optimal in ileum, cecum and ascending colon. In the fluid phase bacteria are 
mixed with nutrients (undigested food remnants, mucus, shed epithelial cells, and metabolites 
of other bacteria) and can live in symbiotic relation with each other. In the more solid feces of 
sigmoid and rectum bacteria, nutrients (e.g. fibers) and bacterial metabolites are fixed and 
contact is more difficult. Local concentrations of nutrients will, therefore, soon decline and 
concentrations of toxic (for bacteria) metabolites may increase. Both may prevent further 
outgrowth of most bacteria. In agreement with this we did not observe major clustering of 
bacteria in solid stool. Only fibers may remain as a nutritional source and only bacteria that can 
ferment these fibers may be able to multiply here. 
In the present study, we show that in each individual, there are no regional differences in the 
composition of the bacterial microflora. In the colon, the liquid and solid fecal lumenal 
contents are mixed and move back and forth by peristaltic movements 25. This prevents the 
development of regional differences in bacterial composition. Even reflux through the ileocecal 
valve may be common since our data show no differences in the composition of the microflora 
between terminal ileum biopsies and feces. These results indicate that regional differences in 
intestinal inflammation, as are often present in Crohn’s disease and ulcerative colitis, cannot be 
explained by regional differences in the composition of the bacterial microflora.  
The probes used in this study can identify most of the bacterial groups of which some species 
are regarded as having probiotic activity: streptococci, lactococci, lactobacilli, enterococci and 
bifidobacteria. Therefore, our data show that also bacteria with probiotic activity have no direct 
contact with intestinal epithelial cells and do not specifically adhere to or multiply at the mucus 
layer. 
Our data show that in healthy individuals there is no direct contact between commensal 
bacteria and epithelial cells. This is in agreement with data of Schultz et al.26. Our data also 
suggest that in the healthy colon there is probably no direct contact of bacteria with cellular 
extensions of dendritic cells in the mucus layer nor with Toll-like receptors in the epithelial cell 
9,12
. Therefore, the mucus layer, containing large amounts of secretory IgA, lysozyme and 
defensins 27, appears to present an important layer of defense against direct contact between the 
mucosa and commensal bacteria. This may be important in the prevention of mucosal 
inflammation and, thus, inflammatory bowel disease.  
Direct contact may take place at M cells. The human colon contains over 10,000 subepithelial 
lymphoid follicles that are covered by an extra thin mucus layer 28. Some of the epithelial cells 
above these follicles are M cells: specialised epithelial cells that allow the penetration of 
particles from the intestinal lumen and bring these in contact with the mucosal immune system. 
Enteropathogens like Salmonella, Shigella and Y ersinia can specifically adhere and endocytose 
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through M cells. In this way, these pathogenic bacteria use M cells as their main portal of entry 
29
. However, M cells can also efficiently take up nonadhering latex particles of bacterial size 8 
and, thus, theoretically also nonadhering commensal bacteria. In the present study, we did not 
observe bacteria adhering to M cells in our biopsies. A possible explanation might be that only 
few lymphoid follicles were studied.  
In conclusion, we have shown that intestinal commensal bacteria live in suspension in the 
lumen and there is no specific group of bacteria adhering to the mucus layer. We did not 
observe direct contact between commensal bacteria and epithelial cells. Therefore, the 
interaction between commensal bacteria and the host may take place via indirect mechanisms. 
We speculate that two mechanisms may be important for the interaction between the host and 
its commensal intestinal microflora (or probiotic bacteria): (a) lumenal sampling of bacteria by 
M cells and (b) soluble signals from bacteria diffusing through the size-selective gelatinous 
mucus layer that is adherent to the epithelial cells 4, 13.To pass the mucus layer, these soluble 
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Summary and discussion 
Summary and discussion 
 
Chapter 1 provides a general introduction to this thesis starting with a brief overview of IBD. 
The possible role in the pathogenesis of IBD of genetic factors, environmental factors, a 
dysregulation of the mucosal immune system, the epithelial-mucus barrier, and the commensal 
intestinal flora is discussed. Furthermore, possible mechanisms by which the commensal 
intestinal microflora interact with the host are discussed. 
 
In chapter 2 a flow cytometry method is described for analysis of immunoglobulins on 
noncultured anaerobic bacteria present in human faecal suspensions. This method is rapid 
(1,000 bacteria per second), sensitive, and reproducable. With this method the interaction 
between the humoral mucosal immune system and the commensal intestinal microflora can be 
analysed. 
 
In chapter 3 the interaction between the humoral mucosal immune system and the 
commensal intestinal microflora in healthy humans was analysed with flow cytometry. 
The in vivo immunoglobulin coating of anaerobic bacteria in fecal samples of 22 healthy 
human volunteers was determined. 45±14% Of fecal bacteria were coated with IgA, 
25±8% with IgG, and 11±6% with IgM. The possible pathophysiological significance of 
this immunoglobulin coating is discussed. The high proportion of intestinal bacteria 
coated with immunoglobulins suggests an extensive interaction of intestinal bacteria and 
the host mucosal immune system. 
 
In chapter 4 the interaction between the humoral mucosal immune system and the commensal 
intestinal microflora in patients with IBD and infectious colitis was analysed. In patients with 
IBD 69±19% of fecal bacteria were coated with IgA, 56±32% with IgG, and 56±29% with 
IgM. Healthy controls had less immunoglobulin coating: respectively 36±12%, 11±4% and 
11±7% (all: p < 0.00001). Immunoglobulin coating in infectious colitis patients was IgA: 
57±14%, IgG: 31±13% (p<0.05, IBD) and IgM: 42±16%. Shortly after remission IBD patients 
had: IgA: 65±20%, IgG: 32±18%, IgM: 40±21%. Long term remission IBD patients had 
normal IgG and IgM, though increased IgA (50±16%) coating. Our hypothesis is that in IBD 
most of the immunoglobulins coated on the bacteria may be of mucosal origin, whereas in 
infectious colitis they may have leaked from the systemic circulation. The increased proportion 
of immunoglobulin-coated intestinal bacteria in patients with IBD add to the existing evidence 
that in IBD there is an increased mucosal immune response against commensal colon bacteria. 
This may either due to a general breakdown of mucosal tolerance to the commensal gut flora or 
to a more intense interaction of intestinal bacteria with the host mucosal immune system. 
 
In chapter 5 the flow cytometry method was extended with double staining with fluorescent in 
situ hybridisation (FISH) in order to determine whether certain bacteria are preferentially 
coated with IgA. Compared to image analysis, this new method is very rapid and possibly 
more sensitive. However, bacterial populations amounting to less than 2% of total could not 
reliably be detected. Furthermore, the sensitivity for detection of immunoglobulin declined due 
to the fixation and extended washings. With FISH several bacterial groups could be identified 
and their IgA coating could be determined. Analysis of 9 fecal samples of healthy individuals 
showed that Bifidobacteria have a preferential coating with IgA. 
 
85
Finally, in chapter 6, the interaction between the commensal colon flora and the host was 
determined at the microscopic anatomical level. Here we investigated the microflora that is 
present at the mucus layer and addressed the following questions: (1) does a specific mucus-
adherent microflora exist ? and (2) is there direct contact between commensal bacteria and 
epithelial cells ? Biopsies were taken of 5 colon regions and of the terminal ileum of 9 subjects 
with a normal colon. Faecal samples were also collected. Bacteria were detected in 
cryosections with FISH with 16S rRNA-targeted probes for all bacteria and specific probes for 
the major representatives. With this sensitive technique bacteria were only observed at the 
lumenal side of the intestinal mucus layer. Very few microcolonies were present at or in the 
mucus layer and the composition of the bacterial microflora present in the faeces was similar to 
that at the mucus layer of the terminal ileum and colon regions. The equal distribution of 
bacterial species suggests that intestinal commensal bacteria live in suspension in the lumen 
and that there is no or little specific mucus-adherent microflora. We did not observe direct 
contact between bacteria and epithelial cells. These findings make an increased direct 
permeation of the intestinal mucus layer by bacteria an unlikely mechanism for the observed 
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Hoofdstuk 1 is de algemene inleiding van dit proefschrift en begint met een kort stukje over 
chronische darmontstekingen (Inflammatory Bowel Disease (IBD)). De mogelijke rol van 
genetische faktoren, omgevings faktoren, dysregulatie van het mucosale afweersysteem, de 
epitheel-mucus barriere en de commensale bakteriële darmflora in de pathogenese van IBD 
wordt besproken. Ook wordt ingegaan op de mogelijke interaktie mechanismen tussen gastheer 
en zijn commensale bakteriële darmflora. 
 
In Hoofdstuk 2 wordt een methode beschreven waarbij met behulp van flow cytometrische 
analyse antilichamen die in vivo gecoat zijn op ongekweekte anaerobe bakteriën in humane 
faeces bepaald kunnen worden. Deze methode is snel (1.000 bakteriën per sekonde), gevoelig 
en goed reproduceerbaar. Met behulp van deze methode kan de interaktie tussen het humorale 
afweer systeem en de commensale bakteriële darmflora geanalyseerd worden. 
 
In Hoofdstuk 3 wordt de interaktie tussen het humorale mucosale afweer systeem en de 
commensale bakteriële darmflora in gezonde mensen geanalyseerd met een flow cytometer. In 
faeces monsters van 22 gezonde vrijwilligers werd de in vivo antilichaam coating van anaerobe 
bakteriën bepaald. Hierbij bleek 45±14% van de bakteriën gecoat met IgA, 25±8% met IgG en 
11±6% met IgM. De mogelijke pathofysiologische betekenis van deze antilichaam coating 
wordt besproken. Het relatief hoge percentage gecoate bakteriën suggereert een intensieve 
interaktie tussen de darmflora en het mucosale afweer systeem. 
 
In Hoofdstuk 4 wordt de interaktie tussen het humorale mucosale afweer systeem en de 
commensale bakteriële darmflora in patienten met IBD en infektieuze colitis geanalyseerd. 
IBD patienten hadden 69±19% van de faecale bakteriën gecoat met IgA, 56±32% met IgG en 
56±29% met IgM. Gezonde proefpersonen hadden een geringere antlichaam coating: 
respectievelijk 36±12%, 11±4% en 11±7% (allen: p < 0.00001). Antilichaam coating bij 
patienten met een infektieuze colitis was IgA: 57±14%, IgG: 31±13% (p<0.05, IBD) en IgM: 
42±16%. IBD patienten waarbij de darmontsteking tot rust kwam hadden: IgA: 65±20%, IgG: 
32±18%, IgM: 40±21%. IBD patienten die meer dan 2 jaar geen aktieve darmontsteking 
hadden gehad hadden normale IgG and IgM, echter toegenomen IgA (50±16%) coating. Onze 
hypothese is dat bij IBD het grootstse deel van de gecoate antilichamen afkomstig is van het 
mucosale afweersysteem, terwijl bij infektieuze colitis de gecoate antilichamen mogelijk 
vanuit het bloed naar de darm zijn gelekt. De toegenomen antlilichaam coating bij IBD 
ondersteund de hypothese dat er bij IBD een toegenomen mucosale afweer respons is tegen de 
eigen commensale bakteriële darmflora. Dit zou veroorzaakt kunnen zijn door hetzij een 
verlies van immunologische mucosale tolerantie voor de commensale darmflora, hetzij een 
toegenomen interaktie tussen de darmbakteriën en het mucosale afweer systeem. 
 
Welke bakteriën zijn nu wel of juist niet met IgA gecoat ? Om deze vraag te beantwoorden 
hebben we in hoofdstuk 5 de boven beschreven flow cytometrische analyse methode 
uitgebreid met fluorescent in situ hybridisation (FISH). In vergelijking met een al bestaande 
beeldverwerkingsmethode is flow cytometrie sneller en mogelijk gevoeliger. Echter bakteriële 
populaties kleiner dan 2% konden niet betrouwbaar met de flow cytometer bepaald worden. 
Ook bleek de gevoeligheid voor het bepalen van de antlichaam coating te verminderen door de 
fixatie en uitgebreide wasstappen. Met FISH konden verschillende bakteriële groepen worden 
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geïdentificeerd en hun IgA coating bepaald. Uit analyse van faeces monsters van 9 gezonde 
proefpersonen bleek dat bifidobakteriën preferentieel gecoat zijn met IgA. 
 
Tenslotte wordt in hoofdstuk 6 de interaktie tussen de commensale bakteriële darmflora en de 
gastheer bestudeerd op microscopisch anatomisch niveau: de darmflora aanwezig bij de 
mucuslaag. We stelden ons de volgende vragen: (1) bestaat er een specifieke mucus-adherente 
darmflora ? en (2) is er direkt kontakt tussen commensale bakteriën en epitheel cellen ? Hiertoe 
hebben we biopsiën genomen uit 5 colon regio’s en uit het terminale ileum van 9 
proefpersonen. Ook werd een faecesmonster verzameld. Bakteriën werden in de coupes 
gedetekteerd m.b.v. FISH met 16S rRNA targeted probes gericht tegen alle bakteriën of 
specifiek voor bepaalde bakteriëe groepen. Met deze gevoelige methode bleken de bakteriën 
alleen aan de lumenzijde van de mucuslaag aanwezig. Slechts enkele microkolonies werden 
gezien in de mucus laag en de samenstelling van de darmflora in de faeces was identiek aan die 
in de mucuslaag. Deze bevindingen suggereren dat commensale bakteriën in het lumen in 
suspensie leven en dat er vermoedelijk geen specifiek mucus-adherente darmflora bestaat. Er 
was geen direkt kontakt tussen bakteriën en epitheelcellen. Deze bevindingen maken het 
onwaarschijnlijk dat een toegenomen penetratie van de mucus door bakteriën verantwoordelijk 






Verkorte samenvatting voor de geïnteresseerde 
leek 
 
In dit proefschrift wordt ingegaan op de wisselwerking tussen het afweersysteem van de darm 
en de darmflora. Eigenlijk is het een wonder dat de dikke darm normaal niet ontstoken is 
omdat er grote hoeveelheden bakteriën in aanwezig zijn. Er werd onderzoek gedaan bij 
gezonde mensen en bij patienten met een chronische darmontsteking (ziekte van Crohn en 
colitis ulcerosa). Er werden verschillende nieuwe onderzoeksmethoden ontwikkeld. In een 
groot deel van het proefschrift wordt gebruik gemaakt van een nieuwe methode waarmee de 
aanwezigheid van antilichamen op darmbakteriën (in de ontlasting) kan worden bepaald. Met 
deze methode werd gevonden dat bij gezonde mensen slechts op een deel van de bakteriën van 
de darmflora antilichamen zitten. Dit kan betekenen dat het afweersysteem van de darm de 
eigen darmflora als lichaamseigen herkent waardoor een darmontsteking voorkomen wordt. Bij 
patienten met een actieve chronische darmontsteking zitten op (bijna) alle bakteriën 
antilichamen. Dit suggereert dat het afweersysteem van de darm van deze patienten de eigen 
darmflora als lichaamsvreemd ziet. Een toegenomen afweerreaktie tegen de eigen darmflora 
zou een rol kunnen spelen bij het ontstaan van chronische darmontstekingen. M.b.v. een 
tweede nieuwe methode werden darmbakteriën zichtbaar gemaakt in darmbiopten van gezonde 
mensen. Het bleek dat darmbakteriën alleen aanwezig zijn op de slijmlaag die de darm bedekt 
en daardoor geen kontakt maken met de onderliggende cellen. Dit zou een darmontsteking bij 
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Dankwoord 
 
De totstandkoming van dit boekje heeft heel wat voeten in de aarde gehad. Mijn 
promotieonderzoek heeft 13 jaar geduurd en in alle fasen van mijn opleiding tot nu uiteindelijk 
maag-darm-lever arts, ben ik door velen ondersteund. Op deze plaats wil ik graag al deze 
personen danken die een bijzondere bijdrage hebben geleverd aan dit proefschrift. 
Vanzelfsprekend kan zo’n opsomming nooit volledig zijn maar ik wil het toch proberen. 
Op de eerste plaats wil ik alle patienten en gezonde vrijwilligers bedanken voor hun bijdrage. 
 
Prof PLM Jansen, promoter, dank ik voor zijn kritische klankbordfunktie. Peter, de vragen die 
jij mij stelde (en die ik mijzelf nooit durfde te stellen) hebben mijn onderzoek en mijn artikelen 
veel sterker gemaakt. Ook heb je vaak terecht geprobeerd om, als ik weer eens dacht dat mijn 
onderzoek een grote doorbraak betekende en ik in hogere sferen verkeerde, mij weer met beide 
benen op de grond te zetten. Wat is het toch moeilijk om mooie resultaten die met veel pijn en 
moeite zijn verzameld zelf kritisch te bekijken. Tenslotte heb je steeds zeer waardevolle 
suggesties gegeven bij het schrijven van mijn artikelen. En vrijwel altijd per kerende post ! 
Hoewel het onderzoeksgebied (poep) ver af staat van de lever (alleen de kleurstof komt 
overeen) heb je mij vind ik goed begeleid. Veel dank. 
 
Prof FGM Kroese, co-promoter, beste Frans. Bij jou op de (voorheen) Histologie en 
Celbiologie heb ik tijdens een keuzeprojekt voor het eerst zelf immunologisch onderzoek 
gedaan. Ik heb er toen van genoten. Ik heb later kontakt met je gezocht om mij te helpen met 
het verder uitbouwen van het concept van antilichaam coating op bakterien. Ik heb veel aan de 
discussies met jou en je correcties van mijn artikelen gehad. Daarnaast was het ook altijd 
gezellig. Veel dank. 
 
Dr PC Limburg, beste Piet. Jij hebt mij in het begin enorm geholpen bij het bedenken en 
opzetten van een analyse methode voor de bakteriële antilichaamcoating. Dank zij jouw 
suggestie heb ik samen met Geert Mesander een flow cytometrie methode opgezet. M.n. bij de 
eerste twee artikelen ben jij van groot belang geweest m.b.t. het schrijven ervan en de 
interpretatie van de gegevens. Ik wil je hierbij hiervoor bedanken. 
 
Geert Mesander, piloot van de flow cytometer. Jij hebt samen met mij de methode op de flow 
cytometer opgezet wat geresulteerd heeft in 3 co-auteurschappen. Ik vind het nog steeds 
geweldig dat je er nooit een punt van gemaakt hebt dat er poep met de flow cytometer gemeten 
werd: ‘If soil and compost were not sufficiently demanding matrices, van der Waaij described 
a flow cytomtry method for the analysis of noncultured anaerobic bacteria present in human 
fecal suspensions. To quote Shapiro, “the subject matter may stink, but the methodology was 
superb.”(Davey, Microbiol Rev 1996;60:641 ev.). 
 
Dr JO Hunter, dear John. We met several years ago in Herborn. Much to my surprise you 
offered me colloboration with the aim to inevstigate the in vivo bacterial immunoglobulin 
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coating in patients with IBD. Not only you provided many paired fecal samples, but you also 
generously funded a technician for the measurements. I am very grateful to you. You offered 
me the oppertunaty to continue resaerch while being in Zwolle. Our succesful colloboration 
resulted in chapter 4.  
 
Dr GF Nelis en Dr BD Westerveld, beste Frits en Dick. Jullie zijn beide van groot belang 
geweest voor mijn carriere. Niet alleen hebben jullie mij geholpen bij het verzamelen van 
facesmonsters bij IBD patienten en patienten met een infectieuze colitis, ook hebben jullie mij 
enthousiast gemaakt voor de maag-darm-leverziekten. Dank hiervoor. 
 
Dr HJM Harmsen, beste Hermie. De laatste jaren ben jij mijn onderzoeksmaatje geweest. We 
hebben veel gediscussieerd (over het wel/niet bestaan van een mucus-adherente microflora) en 
eindeloos veel coupes samen gekeken en besproken. Bij praktische en theoretische vragen was 
je altijd direkt bereid te helpen. Daarnaast ben je ook gewoon aardig. Ik hoop de samenwerking 
op enigerlei wijze voort te zetten. 
 
Medewerkers van de medische microbiologie. In het bijzonder wil ik Erwin Raangs en Linda 
Wildeboer bedanken. Erwin, liters paraformaldehyde 4% heb je voor mij gemaakt en Linda, jij 
hebt mij steeds geholpen met de quantimed en ook enkele metingen voor mij verricht. 
Daarnaast stonden jullie altijd klaar voor vragen of kleine praktische zaken. Ook wil ik Dr GW 
Welling en Prof J Degener bedanken voor hun jarenlange gastvrijheid. Hoewel ik een beetje 
vreemde eend in de bijt was heb ik me altijd bij jullie thuis gevoeld en hebben jullie mij steeds 
alle mogelijkheden gegeven mijn onderzoek op jullie lab te verrichten. Vele anderen wil ik ook 
danken: Auk Wubbema en Annie Visser die vele uren vriescoupes voor mij hebben gesneden, 
Henk en Rudy voor de ondersteuning en gezelligheid.  
 
Er was niet veel van de laatste hoofdstukken tot stand gekomen zonder het vele werk van 
enkele studenten: Mohsen, Marjan en Roland. M.n. Roland heeft bijna een jaar onderzoek bij 
mij gedaan en 2 artikelen bij elkaar gepipetteerd. 
 
De laatstse jaren heb ik ook belangrijke steun gehad van mijn mede maag-darm-leverartsen in 
opleiding: Janneke, Gerard, Liekele en Willem. M.n. met Gerard heb ik jarenlang vele 
enthousiaste en diepgaande discussies gehad over een scala aan wetenschappelijke 
onderwerpen. Ik hoop dat je succesvol zult zijn in je verdere wetenschappelijke carriere. 
Natuurlijk heb ik ook belangrijke steun gehad van Hendrik, Bram, Frans, Jan, Els, Rob en Aad: 
de MDL-stafleden. Ze hebben mij gelegenheid voor research gegeven en ook, samen met de 
endoscopieverpleegkundigen, belangeloos vele biopten genomen. Ik wil alle medewerkers van 
de MDL hiervoor bedanken. 
 
Mijn prive leven is de laatste jaren van mijn proefschrift niet bepaald rimpelloos verlopen. 
Nynke, jou wil ik bedanken voor je steun en de ruimte die je mij gegeven hebt om aan mijn 
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kinderen te passen, mij veel ‘proefschrift ruimte’ gegevn. Veel steun heb ik in deze zware jaren 
ontvangen van ‘mijn buurtje’: Richard, Greetje, Ate en Margrite. Zonder jullie was het mij 
minder goed gelukt mijn emotionele evenwicht te bewaren en was dit proefschrift er nog (lang) 
niet geweest. Het was daarom voor mij duidelijk dat ik jullie zou vragen paranimf van mij te 
zijn. Dank voor jullie ondersteuning op deze voor mij belangrijke dag. 
 
Emeritius Prof D van der Waaij, beste papa. Het onderzoeksbloed heb ik niet van een vreemde. 
Voor zover ik mij kan herinneren wilde ik sinds mijn vierde jaar dokter worden. Lange tijd was 
mijn beeld van het dokter zijn sterk gekleurd door wat jij deed (wetenschappelijk onderzoek 
met proefdieren; als ik in het weekend meeging kreeg ik een gevulde koek). De huisarts zag ik 
nooit, ziekenhuisseries op TV waren er dacht ik nog niet. Op basis van dit beeld, aangelengd 
met nog wat nobele gevoelens en romantische gedachten ben ik geneeskunde gaan studeren. 
Aanvankelijk lag mijn focus in de studie dan ook bij natuurwetenschappelijk preklinsich 
onderzoek. Toen ik na mijn artsexamen graag wetenschappelijk onderzoek wilde doen (en nog 
niet gelijk dokter wilde zijn) op een immunologisch gebied, en er geen geschikte plek in 
Groningen voorhanden was, had jij net een klein potje beschikbaar (voor bijna twee jaar). Na 
lang nadenken heb ik dit aanvaard. Hoewel het voor ons beiden niet altijd even makkelijk was 
heb ik veel aan deze periode gehad. Ik kreeg de mogelijkheid wat te experimenteren en heb 
toen een toevalsbevinding gedaan waar een groot deel van mijn proefschrift op berust: dat er 
antilichamen op fecale bakteriën zitten. Ik had toen geen idee van de betekenis ervan en het 
heeft me jaren gekost voordat ik het enigzins kon plaatsen.  
Mama, als er iemand mijn belangstelling voor natuurwetenschap heeft gevoed en mij gesteund 
heeft in mijn keuzes ben jij het wel. Ik wil jullie beide hierbij danken voor de kansen die jullie 
mij gegeven hebben. 
 
Ook in mijn nieuwe leven word ik gesteund: met belangstellende vragen door mijn 
maatschapsleden Jerrie, Herbert en Michiel; met begrip en ruimte door mijn nieuwe liefde Ilse.  
 
Lieve Hilde, Anne en Jelle. Jullie hebben denk ik, afgezien van mijn afwezigheid af en toe, niet 
veel gemerkt van mijn proefschrift. Jullie zijn het allerbelangrijkste in mijn leven en dit 
proefschrift is daarom ook een beetje voor jullie. Ik hoop dat we nu goede jaren tegemoet gaan. 
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